Advertisement

The Apolipoproteins — Taxonomy and Functions

  • Peter N. Herbert
  • Linda L. Bausserman
  • Paul D. Thompson
  • Richard S. Shulman
  • G. Assmann
  • H.-J. Menzel
Part of the NATO Advanced Science Institutes Series book series (NSSA, volume 58)

Abstract

Our selection of the material included in this chapter was based largely on the specific requests of the students attending the NATO Advanced Study Institute on Arterial Pollution. A brief overview of lipoprotein physiology introduces sections summarizing current knowledge of the chemistry, functions, and distributions of the apolipoproteins.

Keywords

High Density Lipoprotein Cholesteryl Ester Lipoprotein Lipase High Density Lipoprotein Cholesterol Tangier Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    T. Sata, R. J. Havel, and A. L. Jones, Characterization of sub-fractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normolipemic and hyperlipemic humans, J. Lipid Res. 13:757 (1972).PubMedGoogle Scholar
  2. 2.
    R. M. Glickman, K. Kirsch, and K. J. Isselbacher, Fat absorption during inhibition of protein synthesis: Studies of lymph chylomicrons, J. Clin. Invest. 51:356 (1972).PubMedGoogle Scholar
  3. 3.
    R. M. Glickman, J. Khorana, and A. Kilgore, Localization of apolipoprotein B in intestinal epithelial cells, Science 193: 1254 (1976).PubMedGoogle Scholar
  4. 4.
    R. M. Glickman and P. H. R. Green, The intestine as a source of apolipoprotein Al, Proc. Natl. Acad. Sci. U. S. A. 74:2569 (1977).PubMedGoogle Scholar
  5. 5.
    D. Rachmilewitz, J. J. Albers, D. R. Saunders, and M. Fainaru, Apoprotein synthesis by human duodenojejunal mucosa, Gastroenterology 75:677 (1978).PubMedGoogle Scholar
  6. 6.
    G. Schonfeld, E. Bell, and D. H. Alpers, Intestinal apoproteins during fat absorption, J. Clin. Invest. 61:1539 (1978).PubMedGoogle Scholar
  7. 7.
    P. H. R. Green, R. M. Glickman, J. W. Riley, and E. Quinet, Human apolipoprotein A-IV. Intestinal origin and distribution in plasma, J. Clin. Invest. 65:911 (1980).PubMedGoogle Scholar
  8. 8.
    A.-L. Wu and H. G. Windmueller, Relative contributions by liver and intestine to individual plasma apolipoproteins in the rat, J. Biol. Chem. 254:7316 (1979).PubMedGoogle Scholar
  9. 9.
    H. G. Windmueller, P. N. Herbert, and R. I. Levy, Biosynthesis of lymph and plasma lipoprotein apoproteins by isolated per-fused rat liver and intestine, J. Lipid Res. 14:215 (1973).PubMedGoogle Scholar
  10. 10.
    K. Imaizumi, R. J. Havel, M. Fainaru, and J.-L. Vigne, Origin and transport of the A-I and arginine-rich apolipoproteins in mesenteric lymph of rats, J. Lipid Res. 19:1038 (1978).PubMedGoogle Scholar
  11. 11.
    A. -L. Wu and H. G. Windmueller, Identification of circulating apolipoproteins synthesized by rat small intestine in vivo, J. Biol. Chem 253:2525 (1978).PubMedGoogle Scholar
  12. 12.
    H. G. Windmueller and A. -L. Wu, Biosynthesis of plasma apolipoproteins by rat small intestine without dietary or biliary fat, J. Biol. Chem. 256:3012 (1981).PubMedGoogle Scholar
  13. 13.
    S. H. Quarfordt and D. S. Goodman, Metabolism of doubly-labeled chylomicron cholesteryl esters in the rat, J. Lipid Res. 8:264 (1967).PubMedGoogle Scholar
  14. 14.
    A. D. Cooper and P. Y. S. Yu, Rates of removal and degradation of chylomicron remnants by isolated perfused rat liver, J. Lipid Res. 19:635 (1978).PubMedGoogle Scholar
  15. 15.
    L. L. Swift, N. R. Manowitz, G. D. Dunn, and V. S. Lequire, Isolation and characterization of hepatic Golgi lipoproteins from hypercholesterolemic rats, J. Clin. Invest. 66:415 (1980).PubMedGoogle Scholar
  16. 16.
    G. Sigurdsson, A. Nicoll, and B. Lewis, Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects, J. Clin. Invest. 56:1481 (1975).PubMedGoogle Scholar
  17. 17.
    T. Murase and H. Itakura, Accumulation of intermediate density lipoprotein in plasma after intravenous administration of hepatic triglyceride lipase antibody in rats, Atherosclerosis 39:293 (1981).PubMedGoogle Scholar
  18. 18.
    J. R. Patsch, A. M. Gotto, Jr., T. Olivecrona, and S. Eisenberg, Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro, Proc. Natl. Acad. Sci. 75:4519 (1978).PubMedGoogle Scholar
  19. 19.
    G. Sigurdsson, S. -P. Noel, and R. J. Havel, Catabolism of the apoprotein of low density lipoproteins by the isolated per-fused rat liver, J. Lipid Res. 19:628 (1978).PubMedGoogle Scholar
  20. 20.
    J. Shepherd, S. Bicker, A. R. Lorimer, and C. J. Packard, Receptor-mediated low density lipoprotein catabolism in man, J. Lipid Res. 20:999 (1979).PubMedGoogle Scholar
  21. 21.
    R. L. Hamilton, M. C. Williams, C. J. Fielding, and R. J. Havel, Discoidal bilayer structure of nascent high density lipoproteins from perfused rat liver, J. Clin. Invest. 58:667 (1976).PubMedGoogle Scholar
  22. 22.
    P. H. R. Green, A. R. Tall, and R. M. Glickman, Rat intestine secretes discoid high density lipoprotein, J. Clin. Invest. 61:528 (1978).PubMedGoogle Scholar
  23. 23.
    G. Sigurdsson, S. -P. Noel, and R. J. Havel, Quantification of the hepatic contribution to the catabolism of high density lipoproteins in rats, J. Lipid Res. 20:316 (1979).PubMedGoogle Scholar
  24. 24.
    P. Alaupovic, Conceptual development of the classification systems of plasma lipoproteins, in:“Protides of the Biological Fluids,” H. Peeters, ed., Pergamon, Oxford, England (1971).Google Scholar
  25. 25.
    P. N. Herbert, T. M. Forte, R. S. Shulman, M. J. La Piana, E. L. Gong, R. I. Levy, D. S. Fredrickson, and A. V. Nichols, Structural and centrifugation compositional changes attending the ultra-of very low density lipoproteins, Prep. Biochem. 5:93 (1975).PubMedGoogle Scholar
  26. 26.
    M. Fainaru, R. J. Havel, and K. Imaizumi, Apoprotein content of plasma lipoproteins of the rat separated by gel chromatography or ultracentrifugation, Biochem. Med. 17:347 (1977).PubMedGoogle Scholar
  27. 27.
    C. B. Blum, L. Aron, and R. Sciacca, Radioimmunoassay studies of human apolipoprotein E, J. Clin. Invest. 66:1240 (1980).PubMedGoogle Scholar
  28. 28.
    D. B. Zilversmit, L. B. Hughes, and J. Balmer, Stimulation of cholesterol ester exchange by lipoprotein-free rabbit plasma, Biochim. Biophys. Acta 409:393 (1975).PubMedGoogle Scholar
  29. 29.
    J. T. Sparrow, J. D. Morrisett, H. J. Pownall, R. L. Jackson, and A. M. Gotto, Jr., The mechanism of lipid binding by the plasma lipoproteins: synthesis of model peptides, in: “Peptides: Chemistry, Structure and Biology,” R. Walter and J. Meienhofer, eds., Ann Arbor Science, Ann Arbor (1975).Google Scholar
  30. 30.
    H. N. Baker, T. Delahunty, A. M. Gotto, Jr., and R. L. Jackson, The primary structure of high density apolipoprotein-glutamine-I, Proc. Natl. Acad. Sci. U. S. A. 71:3631 (1974).PubMedGoogle Scholar
  31. 31.
    H. B. Brewer, Jr., T. Fairwell, A. LaRue, R. Ronan, A. Houser, and T. J. Bronzert, The amino acid sequence of human apo-I, an apolipoprotein isolated from high density lipoproteins, Biochem. Biophys. Res. Commun. 80:623 (1978).PubMedGoogle Scholar
  32. 32.
    K. H. Weisgraber, T. P. Bersot, R. W. Mahley, G. Franceschini, and C. R. Sirtori, A-I-Milano apoprotein. Isolation and characterization of a cysteine-containing variant of the A^I apoprotein from human high density lipoproteins, J. Clin. Invest. 66:901 (1980).PubMedGoogle Scholar
  33. 33.
    H. B. Brewer, Jr., S. E. Lux, R. Ronan, and K. M. John, Amino acid sequence of human apoLp-Gln-II (apoA-II), an apolipoprotein isolated from the high density lipoprotein complex, Proc. Natl. Acad. Sci. U. S. A. 69:1304 (1972).PubMedGoogle Scholar
  34. 34.
    K. H. Weisgraber, T. P. Bersot, and R. W. Mahley, Isolation and characterization of an apoprotein from the d<1.006 lipoproteins of human and canine lymph homologous with the rat A-IV apoprotein, Biochem. Biophys. Res. Commun. 85:287 (1978).PubMedGoogle Scholar
  35. 35.
    U. Beisiegel and G. Utermann, An apolipoprotein homolog of rat apolipoprotein A-IV in human plasma, Eur. J. Biochem. 93:601 (1979).PubMedGoogle Scholar
  36. 36.
    P. H. R. Green, R. M. Glickman, C. D. Saudek, C. B. Blum, and A. R. Tall, Human intestinal lipoproteins. Studies in chyluric subjects, J. Clin. Invest. 64:233 (1979).PubMedGoogle Scholar
  37. 37.
    P. N. Herbert, G. Assmann, A. M. Gotto, Jr., and D. S. Fredrickson, Familial lipoprotein deficiency (Abetalipoproteinemia and Tangier disease), in:“The Metabolic Basis of Inherited Disease.” J. B. Stanbury, J. B. Wyngaarden, D. S. Fredrickson, J. L. Goldstein, and M. S. Brown, eds., (In press).Google Scholar
  38. 38.
    V. I. Zannis, J. L. Breslow, and A. J. Katz, Isoproteins of human apolipoprotein A-I demonstrated in plasma and intestinal organ culture, J. Biol. Chem. 255:8612 (1980).PubMedGoogle Scholar
  39. 39.
    A. D. McLachlin, Repeated helical pattern in apolipoprotein A-I, Nature 267:465 (1977).Google Scholar
  40. 40.
    C. J. Fielding, V. G. Shore, and P. E. Fielding, A protein cofactor of lecithin:cholesterol acyltransferase, Biochem. Biophys. Res. Commun. 46:1493 (1972).PubMedGoogle Scholar
  41. 41.
    A. K. Soutar, C. W. Garner, H. N. Baker, J. T. Sparrow, R. L. Jackson, A. M. Lotto, and L. C. Smith, Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin:cholesterol acyltransferase, Biochemistry 14:3057 (1975).PubMedGoogle Scholar
  42. 42.
    J. J. Albers, Lecithin:cholesterol acyltransferase, Artery 5:61 (1979).PubMedGoogle Scholar
  43. 43.
    D. Fukushima, S. Yokoyama, D. J. Kroon, F. J. Kezdy, and T. Kaiser, Chain length-function correlation of amphiphilic peptides, J. Biol. Chem. 255:10651 (1980).PubMedGoogle Scholar
  44. 44.
    T. A. Musliner, P. A. Garner, L. O. Henderson, and Peter N. Herbert, Radloimmunoassay of apolipoprotein A-II, Submitted for publication.Google Scholar
  45. 45.
    K. H. Weisgraber and R. W. Mahley, Apoprotein (E-A-II) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction, J. Biol. Chem. 253:6281 (1978).PubMedGoogle Scholar
  46. 46.
    R. L. Jackson, S. J. T. Mao, and A. M. Lotto, Jr., Effects of maleylation on the lipid-binding and immunochemical properties of human plasma high density apolipoprotein A-II, Biochem. Biophys. Res. Commun. 61:1317 (1974).PubMedGoogle Scholar
  47. 47.
    S. E. Lux, K. M. John, S. Fleischer, R. L. Jackson, and A. M. Lotto, Jr., Identification of the lipid-binding cyanogen bromide fragment from the cystine-containing high density apolipoprotein, apolp-gln-II, Biochem. Biophys. Res. Commun. 49:23 (1972).Google Scholar
  48. 48.
    S. J. T. Mao, J. T. Sparrow, E. B. Gilliam, A. M. Lotto, Jr., and R. L. Jackson, Mechanism of lipid-protein interaction in the plasma lipoproteins: lipid-binding properties of synthetic fragments of apolipoprotein A-II, Biochemistry 16:4150 (1977).PubMedGoogle Scholar
  49. 49.
    D. Rachmilewitz, J. J. Albers, D. R. Saunders, and M. Fainaru, Apoprotein synthesis by human duodenojejunal mucosa, Gastroenterology 75:677 (1978).PubMedGoogle Scholar
  50. 50.
    V. I. Zannis, D. N. Kurnit, and J. L. Breslow, Synthesis of apolipoproteins by human fetal intestine and liver in organ culture, Fed. Proc. 40:1635 (1981).Google Scholar
  51. 51.
    C. Jahn, J. C. Osborne, Jr., E. J. Schaefer, and H. B. Brewer, Jr., Activation of the enzymatic activity of hepatic lipase (HTGL) by apoA-II, Circulation 64:IV-229 (1981)Google Scholar
  52. 52.
    G. Bengtsson and T. Olivecrona, The hepatic heparin releasable lipase binds to high density lipoproteins, FEBS Letters 119:290 (1980).PubMedGoogle Scholar
  53. 53.
    J. B. Swaney, H. Reese, and H. A. Eder, Polypeptide composition of rat high density lipoprotein: characterization by SDS-gel electrophoresis, Biochem. Biophys. Res. Commun. 59:513 (1974).PubMedGoogle Scholar
  54. 54.
    A. M. Gotto, W. V. Brown, R. I. Levy, M. E. Birnbaumer and D. S. Fredrickson, Evidence for the identity of the major apoprotein in low density and very low density lipoproteins in normal subjects and patients with familial hyperlipoproteinemia, J. Clin. Invest. 51:1486 (1972).PubMedGoogle Scholar
  55. 55.
    J. L. Granda and A. Scanu, Solubilization and properties of the apoproteins of the very low-and low-density lipoproteins of human serum, Biochemistry 5:3301 (1966).PubMedGoogle Scholar
  56. 56.
    S. Margolis and R. G. Langdon, Studies on human serum ßl-lipoprotein. I. Amino acid composition, J. Biol. Chem. 241:469 (1966).PubMedGoogle Scholar
  57. 57.
    J. P. Kane, D. A. Hardman, and H. E. Paulus, Heterogeneity of apolipoprotein B: Isolation of a new species from human chylomicrons, Proc. Natl. Acad. Sci. U. S. A. 77:2465 (1980).PubMedGoogle Scholar
  58. 58.
    J. P. Kane, E. G. Richards and R. J. Havel, Subunit heterogeneity in human serum beta lipoprotein, Proc. Natl. Acad. Sci. 66:1075 (1970).PubMedGoogle Scholar
  59. 59.
    C. -H. Chen and F. Aladjem, Subunit structure of the apoprotein of human serum low density lipoproteins, Biochem. Biophys. Res. Commun. 60:549 (1974).PubMedGoogle Scholar
  60. 60.
    W. A. Bradley, M. F. Rohde, A. M. Gotto, Jr., and R. L. Jackson, The cyanogen bromide peptides of the apoprotein of low density lipoprotein (apoB): Its molecular weight from a chemical view, Biochem. Biophys. Res. Commun. 81:928 (1978).PubMedGoogle Scholar
  61. 61.
    A. -L. Wu and H. G. Windmueller, Variant forms of plasma apolipoprotein B. Hepatic and intestinal biosynthesis and heterogeneous metabolism in the rat, J. Biol. Chem. 256:3615 (1981).PubMedGoogle Scholar
  62. 62.
    J. Elovson, Y. O. Huang, N. Baker, and R. Kannan, Apolipoprotein B is structurally and metabolically heterogeneous in the rat, Proc. Natl. Acad. Sci. U. S. A. 78:157 (1981).PubMedGoogle Scholar
  63. 63.
    C. E. Sparks and J. B. Marsh, Metabolic heterogeneity of apolipoprotein B in the rat, J. Lipid Res. 22:519 (1981).PubMedGoogle Scholar
  64. 64.
    R. W. Mahley, K. H. Weisgraber, G. W. Melchior, T. L. Innerarity, and K. S. Holcombe, Inhibition of receptor-mediated clearance of lysine and arginine-modified lipoproteins from the plasma of rats and monkeys, Proc. Natl. Acad. Sci. U. S. A. 77:5923 (1980).Google Scholar
  65. 65.
    A. D. Attie, R. C. Pittman, and D. Steinberg, Metabolism of native and of lactosylated human low density lipoprotein: Evidence for two pathways for catabolism of exogenous proteins in rat hepatocytes, Proc. Natl. Acad. Sci. U. S. A. 77:5923 (1980).PubMedGoogle Scholar
  66. 66.
    H. R. Slater, C. J. Packard, S. Bicker, and J. Shepherd, Effects of cholestyramine on receptor-mediated plasma clearance and tissue uptake of human low density lipoproteins in the rabbit, J. Biol. Chem. 255:10210 (1980).PubMedGoogle Scholar
  67. 67.
    J. Shepherd, C. J. Packard, S. Bicker, T. D. V. Lawrie, and H. G. Morgan, Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolism, N. Engl. J. Med. 302:1219 (1980).PubMedGoogle Scholar
  68. 68.
    R. S. Shulman, P. N. Herbert, K. Wehrly, and D. S. Fredrickson, The complete amino acid sequence of C-I (apolp-ser), an apolipoprotein from human very low density lipoproteins, J. Biol. Chem. 250:182 (1975).PubMedGoogle Scholar
  69. 69.
    R. L. Jackson, H. N. Baker, E. B. Gilliam, and A. M. Gotto, Jr., Primary structure of very low density apolipoprotein C-II of human plasma, Proc. Natl. Acad. Sci. U. S. A. 74:1942 (1977).PubMedGoogle Scholar
  70. 70.
    T. A. Musliner, P. N. Herbert, and E. C. Church, Activation of lipoprotein lipase by native and acylated peptides of apolipoprotein C-II, Biochim. Biophys. Acta 573:501 (1979).PubMedGoogle Scholar
  71. 71.
    H. B. Brewer, Jr., R. Shulman, P. Herbert, R. Ronan, and R. Wehrly, The complete amino acid sequence of alanine apolipoprotein (apoC-III), an apolipoprotein from human plasma very low density lipoproteins, J. Biol. Chem. 249:4975 (1974).PubMedGoogle Scholar
  72. 72.
    C. T. Lim, J. Chung, H. J. Kayden, and A. M. Scanu, Apoproteins of human serum high density lipoproteins. Isolation and characterization of the peptides of Sephadex fraction V from normal subjects and patients with abetalipoproteinemia, Biochim. Biophys. Acta 420:332 (1976).PubMedGoogle Scholar
  73. 73.
    J. D. Osborne, Jr., T. J. Bronzert, and H. B. Brewer, Jr., Self association of apoC-I from the human high density lipoprotein complex, J. Biol. Chem. 252:5756 (1977).PubMedGoogle Scholar
  74. 74.
    R. L. Jackson, J. D. Morrisett, J. T. Sparrow, J. P. Segrest, H. J. Pownall, L. C. Smith, H. F. Hoff, and A. M. Gotto, Jr., The interaction of apolipoprotein-serine with phosphatidylcholine, J. Biol. Chem. 249:5314 (1974).PubMedGoogle Scholar
  75. 75.
    A. K. Soutar, C. W. Garner, H. N. Baker, J. T. Sparrow, R. L. Jackson, A. M. Gotto, and L. C. Smith, Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin:cholesterol acyltransferase, Biochemistry 14:3057 (1975).PubMedGoogle Scholar
  76. 76.
    J. J. Albers, Lecithin:cholesterol acyltransferase, Artery 5:61 (1979).PubMedGoogle Scholar
  77. 77.
    P. E. Fielding and C. J. Fielding, A cholesteryl ester transfer complex in human plasma, Proc. Natl. Acad. Sci. U. S. A. 77:3327 (1980).PubMedGoogle Scholar
  78. 78.
    D. Ganesan, R. H. Bradford, P. Alaupovic and W. J. McConathy, Differential activation of lipoprotein lipase from human post-heparin plasma, milk and adipose tissue by polypeptides of human serum apolipoprotein C, FEBS Lett. 15:205 (1971).PubMedGoogle Scholar
  79. 79.
    M. L. Kashyap, L. S. Srivastava, C. Y. Chen, G. Perisutti, M. Campbell, R. F. Lutmer, and C. J. Glueck, Radioimmunoassay of human apolipoprotein C-II. A study in normal and hypertriglyceridemic subjects, J. Clin. Invest. 60:171 (1977).PubMedGoogle Scholar
  80. 80.
    R. J. Havel, L. Kotite, and J. P. Kane, Isoelectric heterogeneity of the cofactor protein for lipoprotein lipase in human blood plasma, Biochem. Med. 21:121 (1979).PubMedGoogle Scholar
  81. 81.
    W. W. Mantulin, M. F. Rohde, A. M. Lotto, Jr., and H. Pownall, The conformational properties of human plasma apolipoprotein C-II, J. Biol. Chem. 255:8185 (1980).PubMedGoogle Scholar
  82. 82.
    A. L. Miller and L. C. Smith, Activation of lipoprotein lipase by apolipoprotein glutamic acid, J. Biol. Chem. 248:3359 (1973).PubMedGoogle Scholar
  83. 83.
    J. Chung, and A. M. Scanu, Isolation, molecular properties, and kinetic characterization of lipoprotein lipase from rat heart, J. Biol. Chem. 252:4202 (1977).PubMedGoogle Scholar
  84. 84.
    T. A. Musliner, E. C. Church, P. N. Herbert, M. J. Kingston, and R. S. Shulman, Lipoprotein lipase cofactor activity of a carboxyl-terminal peptide of apolipoprotein C-II, Proc. Natl. Acad. Sci. U. S. A. 74:5358 (1977).PubMedGoogle Scholar
  85. 85.
    T. A. Musliner, P. N. Herbert, and E. C. Church, Activation of lipoprotein lipase by native and acylated peptides of apolipoprotein C-II, Biochim. Biophys. Acta 573:501 (1979).PubMedGoogle Scholar
  86. 86.
    P. K. J. Kinnunen, R. L. Jackson, L. C. Smith, A. M. Lotto, Jr., and J. T. Sparrow, Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein C-II, Proc. Natl. Acad. Sci. U. S. A. 74:4848 (1977).PubMedGoogle Scholar
  87. 87.
    W. C. Breckenridge, J. A. Little, G. Steiner, A. Chow, and M. Poapst, Hypertriglyceridemia associated with deficiency of apolipoprotein C-II, N. Engl. J. Med. 298:1265 (1978).PubMedGoogle Scholar
  88. 88.
    E. J. Schaefer, D. M. Foster, L. L. Jenkins, F. T. Lindgren, M. Berman, R. I. Levy, and H. B. Brewer, Jr., The composition and metabolism of high density lipoprotein subfractions, Lipids 14:511 (1979).PubMedGoogle Scholar
  89. 89.
    R. S. Shulman, P. N. Herbert, D. S. Fredrickson, K. Wehrly, and H. B. Brewer, Jr., Isolation and alignment of the tryptic peptides of alanine apolipoprotein, an apolipoprotein from human plasma very low density lipoproteins, J. Biol. Chem. 249:4969 (1974).PubMedGoogle Scholar
  90. 90.
    W. V. Brown, R. I. Levy, and D. S. Fredrickson, Further characterization of apolipoproteins from the human plasma very low density lipoproteins, J. Biol. Chem. 245:6588 (1970).PubMedGoogle Scholar
  91. 91.
    J. J. Albers and A. M. Scanu, Isoelectric fractionation and characterization of polypeptides from human serum very low density lipoproteins, Biochim. Biophys. Acta 236:29 (1971).Google Scholar
  92. 92.
    J. D. Morrisett, J. S. K. David, H. J. Pownall, and A. M. Lotto, Jr., Interaction of an apolipoprotein (apolp-alanine) with phosphatidylcholine, Biochemistry 12:1290 (1973).PubMedGoogle Scholar
  93. 93.
    J. T. Sparrow, H. J. Pownall, F.-J. Hsu, L. E. Blumenthal, A. R. Culwell, and A. M. Gotto, Lipid binding by fragments of apolipoprotein C-III-1 obtained by thrombin cleavage, Biochemistry 16:5427 (1977).PubMedGoogle Scholar
  94. 94.
    M. D. Curry, W. J. McConathy, J. D. Fesmire, and P. Alaupovic, Quantitative determination of human apolipoprotein C-III by electroimmunoassay, Biochim. Biophys. Acta 617:503 (1980).PubMedGoogle Scholar
  95. 95.
    A. M. Gotto, R. I. Levy, K. John, and D. S. Fredrickson, On the nature of the protein defect in abetalipoproteinemia, N. Engl. J. Med. 284:813 (1971).PubMedGoogle Scholar
  96. 96.
    L. A. Pottenger, L. E. Frazier, L. H. DuBien, G. S. Getz, and R. W. Wissler, Carbohydrate composition of lipoprotein apoproteins isolated from rat plasma and from the livers of rats fed orotic acid, Biochem. Biophys. Res. Commun. 54:770 (1973).PubMedGoogle Scholar
  97. 97.
    L. Henderson, P. Herbert, H. Windmueller, and R. Krauss, The C apolipoproteins of the orotic acid rat: A model for abetalipoproteinemia, Circulation 50:111–114 (1974).Google Scholar
  98. 98.
    W. V. Brown and M. L. Baginsky, Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein, Biochem. Biophys. Res. Commun. 46:375 (1972).PubMedGoogle Scholar
  99. 99.
    R. M. Krauss, P. N. Herbert, R. I. Levy, and D. S. Fredrickson, Further observations on the activation and inhibition of lipoprotein lipase by apolipoproteins, Circ. Res. 33:403 (1973).PubMedGoogle Scholar
  100. 100.
    W. J. McConathy and P. Alaupovic, Isolation and partial characterization of apolipoprotein D: A new protein moiety of the human plasma lipoprotein system, FEBS Lett. 37:178 (1973).PubMedGoogle Scholar
  101. 101.
    G. M. Kostner, Studies of the composition and structure of human serum lipoproteins: Isolation and partial characterization of apolipoprotein A-III, Biochim. Biophys. Acta 336:383 (1974).Google Scholar
  102. 102.
    J. J. Albers, M. C. Cheung, S. L. Ewens, and J. H. Tollefson, Characterization and immunoassay of apolipoprotein D, Atherosclerosis 39:395 (1981).PubMedGoogle Scholar
  103. 103.
    W. J. McConathy and P. Alaupovic, Studies on the isolation and partial characterization of apolipoprotein D and lipoprotein D of human plasma, Biochemistry 15:515 (1976).PubMedGoogle Scholar
  104. 104.
    T. Chajek and C. J. Fielding, Isolation and characterization of a human serum cholesteryl ester transfer protein, Proc. Natl. Acad. Sci. U. S. A. 75:3445 (1978).PubMedGoogle Scholar
  105. 105.
    M. D. Curry, W. J. McConathy, and P. Alaupovic, Quantitative determination of human apolipoprotein D by electroimmunoassay and radial immunodiffusion, Biochim. Biophys. Acta 491:232 (1977).PubMedGoogle Scholar
  106. 106.
    G. Kostner, Studies on the cofactor requirement for lecithin: cholesterol acyltransferase, Scand. J. Clin. Lab. Invest. 33, Suppl. 137:19 (1974).Google Scholar
  107. 107.
    J. J. Albers, Lecithin:cholesterol acyltransferase, Artery 5:61 (1979).PubMedGoogle Scholar
  108. 108.
    S. O. Olofsson and A. Gustafson, Degradation of high density lipoproteins (HDL) in vitro, Scand. J. Clin. Lab. Invest. 33, Suppl. 137:57 (1974).Google Scholar
  109. 109.
    P. E. Fielding and C. J. Fielding, A cholesteryl ester transfer complex in human plasma, Proc. Natl. Acad. Sci. U. S. A. 77:3327 (1980).PubMedGoogle Scholar
  110. 110.
    R. E. Morton and D. B. Zilversmit, The separation of apolipoprotein D from cholesteryl ester transfer protein, Biochim. Biophys. Acta 663:350 (1981).PubMedGoogle Scholar
  111. 111.
    F. A. Shelburne and S. H. Quarfordt, A new apoprotein of human plasma very low density lipoproteins, J. Biol. Chem. 249:1428 (1974).PubMedGoogle Scholar
  112. 112.
    V. I. Zannis and J. L. Breslow, Characterization of a unique human apolipoprotein E variant associated with type III hyperlipoproteinemia, J. Biol. Chem. 255:1759 (1980).PubMedGoogle Scholar
  113. 113.
    N. Tada, P. J. Nestel, N. Fidge, and G. Campbell, Abnormal apolipoprotein composition in alcoholic hepatitis, Biochim. Biophys. Acta 664:207 (1981).PubMedGoogle Scholar
  114. 114.
    N. Tada, N. Fidge, and P. Nestel, Identification and characterization of mixed disulphide complexes of E apoprotein in high density lipoprotein of subjects with acute alcoholic hepatitis, Biochem. Biophys. Res. Commun. 90:297 (1979).PubMedGoogle Scholar
  115. 115.
    P. N. Herbert, R. J. Heinen, L. L. Bausserman, K. M. Lynch, L. O. Henderson, and T. A. Musliner, Abetalipoproteinemia and hypobetalipoproteinemia: Questions still exceed insights, in:“Atherosclerosis V. Proceedings of the Fifth International Symposium on Atherosclerosis,” A. M. Gotto, Jr., L. C. Smith, and B. Allen, Eds., Springer-Verlag, New York (1980).Google Scholar
  116. 116.
    G. Utermann, Isolation and partial characterization of an arginine-rich apolipoprotein from human plasma very low density lipoproteins: apolipoprotein E, Hoppe-Seylers Z. Physiol. Chem. 356:1113 (1975).PubMedGoogle Scholar
  117. 117.
    K. H. Weisgraber, S. C. Rall, Jr., and R. W. Mahley, Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apoE isoforms, J. Biol. Chem. 256:9077 (1981).PubMedGoogle Scholar
  118. 118.
    G. R. Warnick, C. Mayfield, J. J. Albers, and W. R. Hazzard, Gel isoelectric focusing method for specific diagnosis of familial hyperlipoproteinemia type 3, Clin. Chem. 25:279 (1979).PubMedGoogle Scholar
  119. 119.
    G. Utermann, M. Hees, and A. Steinmetz, Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man, Nature 269:604 (1977).PubMedGoogle Scholar
  120. 120.
    G. Utermann, G. Albrecht, and A. Steinmetz, Polymorphism of apolipoprotein E. I. Methodological aspects and diagnosis of hyperlipoproteinemia type III without ultracentrifugation, Clin. Genet. 14:351 (1978).PubMedGoogle Scholar
  121. 121.
    R. J. Havel, L. Kotite, J.-L. Vigne, J. P. Kane, P. Tun, N Phillips, and G. C. Chen, Radioimmunoassay of human arginine-rich apolipoprotein, apoprotein E, J. Clin. Invest. 66:1351 (1980).PubMedGoogle Scholar
  122. 122.
    J. M. Falko, G. Schonfeld, J. L. Witztum, J. B. Kolar, S. W. Wiedman, and R. Steelman, Effects of diet on apoprotein E levels and on the apoprotein E subspecies in human plasma lipoproteins, J. Clin. Endocrinol. Metab. 50:521 (1980).PubMedGoogle Scholar
  123. 123.
    V. I. Zannis and J. L. Breslow, Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification, Biochemistry 20:1033 (1981).PubMedGoogle Scholar
  124. 124.
    V. I. Zannis, P. W. Just, and J. L. Breslow, Human apolipoprotein E isoprotein subclasses are genetically determined, Am. J. Hum. Genet. 33:11 (1981).PubMedGoogle Scholar
  125. 125.
    T. L. Innerarity and R. W. Mahley, Enhanced binding by cultured human fibroblasts of apoE-containing lipoproteins as compared with low density lipoproteins, Biochemistry 17:1440 (1978).PubMedGoogle Scholar
  126. 126.
    Y. Chao, E. E. Windler, G. C. Chen, and R. J. Havel, Hepatic catabolism of rat and human lipoproteins in rats treated with l7aethinyl estradiol, J. Biol. Chem. 254:11360 (1979).PubMedGoogle Scholar
  127. 127.
    R. J. Havel, Y. Chao, E. E. Windler, L. Kotite, and L. S. S. Guo, Isoprotein specificity in the hepatic uptake of apolipoprotein E and the pathogenesis of familial dysbetalipoproteinemia. Proc. Natl. Acad. Sci. U. S. A. 77:4349 (1980).PubMedGoogle Scholar
  128. 128.
    R. E. Gregg, L. A. Zech, E. J. Schaefer, and H. B. Brewer, Jr., Type III hyperlipoproteinemia: Defective metabolism of an abnormal apolipoprotein E, Science 211:584 (1981).PubMedGoogle Scholar
  129. 129.
    C. B. Blum, L. Aron, and R. Sciacca, Radioimmunoassay studies of human apolipoprotein E, J. Clin. Invest. 66:1240 (1980).PubMedGoogle Scholar
  130. 130.
    R. S. Kushwaha, W. R. Hazzard, P. W. Wahl, and J. J. Hoover, Type III hyperlipoproteinemia: Diagnosis in whole plasma by apolipoprotein E immunoassay, Ann. Int. Med. 87:509 (1977).PubMedGoogle Scholar
  131. 131.
    J. D. Morrisett, R. L. Jackson, and A. M. Gotto, Jr., Lipid-protein interactions in the plasma lipoproteins, Biochim. Biophys. Acta 472:93 (1977).PubMedGoogle Scholar
  132. 132.
    R. I. Roth, R. L. Jackson, H. J. Pownall, and A. M. Gotto, Jr., Interaction of plasma “arginine-rich” apolipoprotein with dimyristoylphosphatidylcholine, Biochemistry 16:5030 (1977).PubMedGoogle Scholar
  133. 133.
    S. -O. Olofsson, W. J. McConathy, and P. Alaupovic, Isolation and partial characterization of a new acidic apolipoprotein (apolipoprotein F) from high density lipoproteins of human plasma, Biochemistry 17:1032 (1978).PubMedGoogle Scholar
  134. 134.
    M. Ayrault-Jarrier, J.-F. Alix, and J. Polonovski, Une nouvelle proteine des lipoproteines du serum humain: isolement et caracterisation partielle d’une apolipoproteine G, Biochimie 60:65 (1978).PubMedGoogle Scholar
  135. 135.
    Y. Nakaya, E. J. Schaefer, and H. B. Brewer, Jr., Activation of human post heparin lipoprotein lipase by apolipoprotein H 02-glycoprotein I), Biochem. Biophys. Res. Commun. 95:1168 (1980).PubMedGoogle Scholar
  136. 136.
    E. Polz and G. M. Kostner, The binding of 132-glycoprotein-I to human serum lipoproteins, FEBS Lett. 102:183 (1979).PubMedGoogle Scholar
  137. 137.
    H. E. Schultze, K. Heide, and H. Haupt, Über ein bisher unbekanntes niedermolekulares 02-Globulin des Humanserums, Naturwissenschaften 48:719 (1961).Google Scholar
  138. 138.
    E. Polz and G. M. Kostner, Binding of 02-glycoprotein-1 to intralipid: determination of the dissociation constant, Biochem. Biophys. Res. Commun. 90:1305 (1979).PubMedGoogle Scholar
  139. 139.
    E. Polz, G. M. Kostner, and A. Holasek, Studies on the protein composition of human serum very low density lipoproteins: demonstration of the 02-glycoprotein-1, Hoppe-Seyler’s Z. Physiol. Chem. 360:1061 (1979).PubMedGoogle Scholar
  140. 140.
    T. Sata, R. J. Havel, L. Kotite, and J. P. Kane, New protein in human blood plasma, rich in proline, with lipid-binding properties, Proc. Natl. Acad. Sci. U. S. A. 73:1063 (1976).PubMedGoogle Scholar
  141. 141.
    E. P. Benditt and N. Eriksen, Amyloid protein SAA is associated with high density lipoprotein from human serum, Proc. Natl. Acad. Sci. U. S. A. 74:4025 (1977).PubMedGoogle Scholar
  142. 142.
    L. L. Bausserman, P. N. Herbert, and K. P. W. J. McAdam, Heterogeneity of human serum amyloid A proteins, J. Exp. Med. 152:641 (1980).PubMedGoogle Scholar
  143. 143.
    B. Shore and V. Shore, Isolation and characterization of polypeptides of human serum lipoproteins, Biochemistry 8:4510 (1969).PubMedGoogle Scholar
  144. 1.
    G. Heiss, N.J. Johnson, S. Reiland, C.E. Davis, H.A. Tyroler,The epidemiology of plasma high-density lipoprotein cholesterol levels, Circulation 62(IV):116–136 (1980).Google Scholar
  145. 2.
    W.B. Kannel, W.P. Castelli, T. Gordon, Cholesterol in the prediction of atherosclerotic disease, Ann Intern Med 90:85–91 (1979).PubMedGoogle Scholar
  146. 3.
    G.G. Rhoads, C.L. Gulbrandsen, A. Kagan, Serum lipoproteins and coronary heart disease in a population study of hawaii japanese men, N Engl J Med 294:293–298 (1976).PubMedGoogle Scholar
  147. 4.
    W.P. Castelli, J.T. Doyle, T. Gordon, C.G. Hames, M.C. Hjortland, S.B. Hulley, A. Kagan, W.J. Zukel, HDL cholesterol and other lipids in coronary heart disease, Circulation 55:767–772 (1977).PubMedGoogle Scholar
  148. 5.
    K. Berg, A. Borresen, G. Dahlen, Serum high density lipoprotein and atherosclerotic heart disease, Lancet 1:499–501 (1976).PubMedGoogle Scholar
  149. 6.
    T. Gordon, W.P. Castelli, M.C. Hjortland, W.B. Kannel, T.R. Dawber, High density lipoprotein as a protective factor against coronary heart disease, An J Med 62:707–714 (1977)Google Scholar
  150. 7.
    N.E. Miller, D.S. Thelle, O.H. Forde, O.D. Mjos, The Tromoso heart study, Lancet 1:965–968 (1977).PubMedGoogle Scholar
  151. 8.
    U. Goldbourt, J.H. Medalie, High density lipoprotein cholesterol and incidence of coronary heart disease - the Israeli ischemic heart disease study, Am J Epidemiol 109:296–308 (1979).PubMedGoogle Scholar
  152. 9.
    D.M. Kramsch, W. Hollander, The interaction of serum and arterial lipoproteins with elastin of the arterial intima and its role in the lipid accumulation in atherosclerotic plaques, J Clin Invest 52:236–247 (1973).PubMedGoogle Scholar
  153. 10.
    E.B. Smith, R.S. Slater, J.A. Hunter, Quantitative studies on fibrinogen and low-density lipoprotein in human aortic intima, Atherosclerosis 18:479–487 (1973).PubMedGoogle Scholar
  154. 11.
    H.F. Hoff, R.L. Jackson, S.J. Mao, A. M. Gotto, Jr., Localization of low-density lipoproteins in atherosclerotic lesions from human normolipemics employing a purified florescent-labeled antibody, Biochim Biophys Acta 351:407–415 (1974).PubMedGoogle Scholar
  155. 12.
    O. Stein, Y. Stein, The removal of cholesterol from Landschutz ascites cells by high-density apolipoprotein, Biochim Biophys Acta 326:232–244 (1973).PubMedGoogle Scholar
  156. 13.
    Y. Stein, M.C. Glandeaud, M. Fainaru, O. Stein, The removal of cholesterol from aortic smooth muscle cells in culture and Landschutz ascites cells by fractions of human high-density apolipoprotein, Biochim Biophys Acta 380:106–118 (1975).PubMedGoogle Scholar
  157. 14.
    R. L. Jackson, A. M. Gotto, O. Stein, Y. Stein, A comparative study on the removal of cellular lipids from Landschutz ascites cells by human plasma apolipoproteins, J Biol Chem 250:7204–7209 (1975).PubMedGoogle Scholar
  158. 15.
    O. Stein, M. Fainaru, Y. Stein, The role of lysophosphatidylcholine and apolipoprotein al in the cholesterol-removing capacity of lipoprotein-deficient serum in tissue culture, Biochim Biophys Acta 574:495–504 (1979).PubMedGoogle Scholar
  159. 16.
    R.J. Daniels, L.S. Guertler, T.S. Parker, D. Steinberg, Studies on the rate of efflux of cholesterol from cultured human skin fibroblasts, J Biol Chem 256:4978–4983 (1981).PubMedGoogle Scholar
  160. 17.
    J.F. Oram, J.J. Albers, M.C. Cheung, E.L. Bierman, The effects of subfractions of high density lipoprotein on cholesterol efflux from cultured fibroblasts, J Biol Chem 256:8348–8356 (1981).PubMedGoogle Scholar
  161. 18.
    Y.K. Ho, M.S. Brown, J.L. Goldstein, Hydrolysis and excretion of cytoplasmic cholesteryl esters by macrophages: stimulation by high density lipoprotein and other agents, J Lipid Res 21:391–398 (1980).PubMedGoogle Scholar
  162. 19.
    D.W. Anderson, A.V. Nichols, S.S. Pan, F.T. Lindgren, High density lipoprotein distribution, Atherosclerosis 29:161–179 (1978).PubMedGoogle Scholar
  163. 20.
    T.E. Carew, S.B. Hayes, T. Koschinsky, D. Steinberg, A mechanism by which high-density lipoproteins may slow the atherogenic process, Lancet 1:1315–1317 (1976).PubMedGoogle Scholar
  164. 21.
    H.G. Windmueller, P.N. Herbert, R.I Levy, Biosynthesis of lymph and plasma lipoprotein apoproteins by isolated perfused rat liver and intestine, J Lipid Res 14:215–223 (1973).PubMedGoogle Scholar
  165. 22.
    T.E. Felker, M. Fainaru, R.L. Hamilton, R.J. Havel, Secretion of the arginine-rich and a-i apolipoproteins by the isolated perfused rate liver, J Lipid Res 18:465–472 (1977).PubMedGoogle Scholar
  166. 23.
    G. Assmann, A. Capurso, E. Smootz, U. Weliner, Apoprotein A metabolism in Tangier disease, Atherosclerosis 30:321–332 (1978).PubMedGoogle Scholar
  167. 24.
    R.M. Glickman, A. Kilgore, J. Khorana, Chylomicron apoprotein localization within rat intestinal epithelium: studies of normal and impaired lipid absorption, J Lipid Res 19:260–268 (1978).PubMedGoogle Scholar
  168. 25.
    R.L. Hamilton, M.C. Williams, C.J. Fielding, R.J. Havel, Discoidal bilayer structure of nascent high density lipoproteins from perfused rat liver, J Clin Invest 58:667–680 (1976).PubMedGoogle Scholar
  169. 26.
    P.H. Green, A.R. Tall, R.M. Glickman, Rat intestine secretes discoid high density lipoprotein, J Clin Invest 61:528–534 (1978).PubMedGoogle Scholar
  170. 27.
    C.D. Mitchell, W.C. King, K.R. Applegate, T. Forte, J.A. Glomset, K.R. Norum, E. Gjone, Characterization of apolipoprotein E-rich high density lipoproteins in familial lecithin: cholesterol acyltransferase deficiency, J Lipid Res 21:625–634 (1980).PubMedGoogle Scholar
  171. 28.
    S.M. Sabesin, H.L. Hawkins, L. Kuiken, J.B. Ragland, Abnormal plasma lipoproteins and lecithin-cholesterol acyltransferase deficiency in alcoholic liver disease, Gastroenterology 72:510–518 (1977).PubMedGoogle Scholar
  172. 29.
    R.J. Havel, J.P. Kane, E.O. Balasse, N. Segel, L.V. Basso, Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans, J Clin Invest 49:2017 (1970).PubMedGoogle Scholar
  173. 30.
    C.J. Fielding, P.E. Fielding, Purification and substrate specificity of lecithin-cholesterol acyltransferase from human plasma, FEES Lett 15:335–358 (1971).Google Scholar
  174. 31.
    T.G. Redgrave, D.M. Small, Quantitation of the transfer of surface phospholipid of chylomicrons to the high density lipoprotein fraction during the catabolism of chylomicrons in the rat, J Clin Invest 64:162 (1979).PubMedGoogle Scholar
  175. 32.
    A.R. Tall, P.H. Green, R.M. Glickman, J.W. Riley, Metabolic fat of chylomicron phospholipids and apoproteins in the rat, J Clin Invest 64:977–989 (1979).PubMedGoogle Scholar
  176. 33.
    J.R. Patsch, A.M. Gotto,Jr., T. Olivecrona, S. Eisenberg, Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro, Proc Natl Acad Sci 75:4519–4523 (1978).PubMedGoogle Scholar
  177. 34.
    M. Kekki, Lipoprotein-lipase action determining plasma high density lipoprotein cholesterol level in adult normolipaemics, Atherosclerosis 37:143–150 (1980).PubMedGoogle Scholar
  178. 35.
    J.J. Albers, G.R. Warnick, M.C. Chenng, Quantitation of high density lipoproteins, Lipids 13:926–932 (1978).PubMedGoogle Scholar
  179. 36.
    G. Heiss, I. Tamir, C.E. Davis, H.A. Tyroler, B.M. Rifkind, G. Schnofeld, D. Jacobs, I.D. Frantz, Jr., Lipoprotein-cholesterol distributions in selected North American populations: The Lipid Research Clinics Program Prevalence Study, Circulation 61:302–315 (1980).PubMedGoogle Scholar
  180. 37.
    R. Beaglehole, D.C. Trost, I. Tamir, P. Kwiterovich, C.J. Glueck, W. Insull, B. Christensen, Plasma high-density lipoprotein cholesterol in children and young adults, Circulation 62(IV):83–92 (1980).Google Scholar
  181. 38.
    D. Mjos, D.S. Thelle, O.H. Forde, H. Vik-Mo, Family study of high density lipoprotein cholesterol and the relation to age and sex, Acta Med Scand 201:323–329 (1977).PubMedGoogle Scholar
  182. 39.
    C.J. Glueck, R.W. Fallat, F. Millett, P. Gartside, R.C. Elston, R.C. Go, Familial hyper-alpha-lipoproteinemia: studies in eighteen kindreds, Metabolism 24:1243–1265 (1975).PubMedGoogle Scholar
  183. 40.
    R.M. Siervogel, J.A. Morrison, K. Kelly, M. Mellies, P. Gartside, C.J. Glueck, Familial hyper-alphalipoproteinemia in 26 kindreds, Clin Genet 17:13–25 (1980).PubMedGoogle Scholar
  184. 41.
    M.E. Morton, C.J. MacLean, A. Kagan, C.L. Gulbrandsen, G.G. Rhoads, S. Yee, R. Lew, Commingling in distributions of lipids and related variables, Amer J. Hum Genet 29:52–59 (1977).PubMedGoogle Scholar
  185. 42.
    N.E. Morton, C.L. Gulbrandsen, G.G. Rhoads, A. Kagan, R. Lew, Major loci for lipoprotein concentrations, Amer J. Hum Genet 30:583–589 (1978).PubMedGoogle Scholar
  186. 43.
    D.C. Rao, N.E. Morton, C.L. Gulbrandsen, G.G. Rhoads, A. Kagan, S. Yee, Cultural and biological determinants of lipoprotein concentrations, Ann Hum Genet 42:467–477 (1979).PubMedGoogle Scholar
  187. 44.
    M.S. Nupuf, W.H. Sutherland, High density lipoprotein levels in children of young men with ischaemic heart disease, Atherosclerosis 33:365–370 (1979).PubMedGoogle Scholar
  188. 45.
    H. Micheli, D. Pometta, C. Jornot, J.R. Scherrer, High density lipoprotein cholesterol in male relatives of patients with coronary heart disease, Atherosclerosis 32:269–276 (1979).PubMedGoogle Scholar
  189. 46.
    P.N. Herbert, G. Assmann, A.M. Gotto, D.S. Fredrickson, Familial lipoprotein deficiency, in “The Metabolic Basis of Inherited Disease,” J.B. Stanbury, et al, McGraw-Hill Book Co., New York (1982).Google Scholar
  190. 47.
    H.A. Tyroler, C.J. Glueck, B. Christensen, P.O. Kwiterovich, Jr., Plasma high-density lipoprotein cholesterol comparisons in black and white populations, Circulation 62(IV):99–107 (1980).Google Scholar
  191. 48.
    Y. Yano, N. Irie, Y. Homma, M. Tsushima, I. Takeuchi, N. Nakaya, Y. Goto, High density lipoprotein cholesterol levels in the Japanese, Atherosclerosis 36:173–181 (1980).PubMedGoogle Scholar
  192. 49.
    B. Lewis, A. Chait, G. Sigurdsson, M. Mancini, E. Farinaro, P. Oriente, L.A. Carlson, M. Ericsson, H. Micheli, D. Pometta, Serum lipoproteins in four European communities: a quantitative comparison, Bur J Clin Invest 8:165–173 (1978).Google Scholar
  193. 50.
    J. Burslem, G. Schonfeld, M.A. Howald, S.W. Weidman, J.P. Miller, Plasma apoprotein and lipoprotein lipid levels in vegetarians, Metabolism 27:711–719 (1978).PubMedGoogle Scholar
  194. 51.
    J.T. Knuiman, R.J. Hermus, J.G. Hautvast, Serum total and high density lipoprotein (HDL) cholesterol concentrations in rural and urban boys from 16 countries, Atherosclerosis 36:529–537 (1980).PubMedGoogle Scholar
  195. 52.
    W.E. Connor, M.T. Cerqueira, R.W. Connor, R.B. Wallace, M.R. Malinow, H.R. Casdorph, The plasma lipids, lipoproteins, and diet of the Tarahumara Indians of Mexico, Am J Clin Nutr 31:1131–1142 (1978).PubMedGoogle Scholar
  196. 53.
    D.E. Wilson, R.S. Lees, Metabolic relationships among the plasma lipoproteins, J Clin Invest 51:1051–1056 (1972).PubMedGoogle Scholar
  197. 54.
    G.H. Hartung, J.P. Foreyt, R.E. Mitchell, I. Vlasek, A.M. Gotto,Jr., Relation of diet to high-density lipoprotein cholesterol in middle-aged marathon runners, joggers, and inactive men, N Engl J Med 302:357–361 (1980).PubMedGoogle Scholar
  198. 55.
    R.W. Mahley, K.H. Weisgraber, T. Innerarity, H.B. Brewer, G. Assmann, Swine lipoproteins and atherosclerosis, Biochemistry 14:2817–2823 (1975).PubMedGoogle Scholar
  199. 56.
    R.W. Mahley, R.P. Bersot, T.L. Innerarity, A. Lipson, S. Margolis, Alterations in human high-density lipoproteins, with or without increased plasma-cholesterol, induced by diets high in cholesterol, Lancet 11:807–809 (1978).Google Scholar
  200. 57.
    N. Ernst, M. Fisher, W. Smith, T. Gordon, B.M. Rifkind, J.A. Little, M.A. Mishkel, 0.D. Williams, The association of plasma high-density lipoprotein cholesterol with dietary intake and alcohol consumption, Circulation 62(IV):41–52 (1980).Google Scholar
  201. 58.
    D. Applebaum-Bowden, W.R. Hazzard, J. Cain, M.C. Cheung, R.S. Kushwaha, J.J. Albers, Short-term egg yolk feeding in humans, Atherosclerosis 33:385–396 (1979).PubMedGoogle Scholar
  202. 59.
    A. Chait, A. Onitiri, A. Nicoll, E. Rabaya, J. Davies, B. Lewis, Reduction of serum triglyceride levels by polyunsaturated fat, Atherosclerosis 20:347–364 (1974).PubMedGoogle Scholar
  203. 60.
    P.J. Nestel, N. Havenstein, Y. Homma, T.W. Scott, L.J. Cook, Increased sterol excretion with polyunsaturated-fat high-cholesterol diets, Metabolism 24:189–198 (1975).PubMedGoogle Scholar
  204. 61.
    J. Shepherd, C.J. Packard, J.R. Patsch, A.M. Gotto, O.D. Taunton, Effects of dietary polyunsaturated and saturated fat on the properties of high density lipoproteins and the metabolism of apolipoprotein A-I, J Clin Invest 61:1582–1592 (1978).PubMedGoogle Scholar
  205. 62.
    B. Vessby, J. Boberg, I.B. Gustafsson, B. Karlstrom, H. Lithell, A.M. Ostlund-Lindqvist, Reduction of high density lipoprotein cholesterol and apolipoprotein A-IGoogle Scholar
  206. 63.
    N. Ernst, P. Bowen, M. Fisher, E.J. Schaefer, R.I. Levy, Changes in plasma lipids and lipoproteins after a modifed fat diet, Lancet 11:111–112 (1980).Google Scholar
  207. 64.
    I. Hjermann, S. C. Enger, A. Helgeland, I. Holme, P. Leren, K. Trygg, The effect of dietary changes on high density lipoprotein cholesterol, An J Med 66:105–109 (1979).Google Scholar
  208. 65.
    C.J. Glueck, H.L. Taylor, D. Jacobs, J.A. Morrison, R. Beaglehole, O.D. Williams, Plasma high-density lipoprotein cholesterol: association with measurements of body mass, Circulation 62(IV):62–69 (1980).Google Scholar
  209. 66.
    N.R. Phillips, R.J. Havel, J.P. Kane, Levels and interrelationships of serum and lipoprotein cholesterol and triglycerides, Arterisclerosis 1:13–24 (1981).Google Scholar
  210. 67.
    P.D. Thompson, R.W. Jeffery, R.R. Wing, P.D. Wood, Unexpected decrease in plasma high density lipoprotein cholesterol with weight loss, An J Clin Nutr 32:2016–2021 (1979).Google Scholar
  211. 68.
    J.R. Taskinen, E.A. Nikkila, Effects of caloric restriction on lipid metabolism in man, Atherosclerosis 32:289–299 (1979).PubMedGoogle Scholar
  212. 69.
    F. Contaldo, P. Strazzullo, A. Postiglione, G. Riccardi, L. Patti, G. Di Biase, M. Mancini, Plasma high density lipoprotein in severe obesity after stable weight loss, Atherosclerosis 37:163–167 (1980).PubMedGoogle Scholar
  213. 70.
    H.O. Bang, J. Dyerberg, A.B. Nielsen, Plasma lipid and lipoprotein pattern in Greenlandic west-coast Eskimos, Lancet 1:1143–1146 (1971).PubMedGoogle Scholar
  214. 71.
    A. Lehtonen, J. Viikari, The effect of vigorous physical activity at work on serum lipids with a special reference to serum high-density lipoprotein cholesterol, Acta Physiol Scand 104:117–121 (1978).PubMedGoogle Scholar
  215. 72.
    P.D. Wood, W. Haskell, H. Klein, S. Lewis, M.P. Stern, J.W. Farquhar, The distribution of plasma lipoproteins in middle-aged male runners, Metabolism 11:1249–1257 (1976).Google Scholar
  216. 73.
    A. Lehtonen, J. Viikari, Serum triglycerides and cholesterol and serum high-density lipoprotein cholesterol in highly physically active men, Acta Med Scand 204:111–114 (1978). concentrations by a lipid-lowering diet, Atherosclerosis 35:21–27 (1980).Google Scholar
  217. 74.
    S.C. Enger, K. Herbjornsen, J. Serikssen, A. Fretland, High density lipoproteins (HDL) and physical activity: the influence of physical exercise, age and smoking on HDLcholesterol and the HDL-total cholesterol ratio, Scand J Clin Lab Invest 37:251–255 (1977).PubMedGoogle Scholar
  218. 75.
    A. Lopez, R. Vial, L. Balart, G. Arroyave, Effect of exercise and physical fitness on serum lipids and lipoproteins, Atherosclerosis 20:1–9 (1974).PubMedGoogle Scholar
  219. 76.
    J.K. Huttunen, E. Lansimies, E. Voutilainen, C. Ehnholm, E. Heitanen, I. Penttila, O. Siitonen, R. Rauramaa, Effect of moderate physical exercise on serum lipoproteins, Circulation 60:1220–1229 (1979).PubMedGoogle Scholar
  220. 77.
    P.A. Farrell, J. Barboriak, The time course of alterations in plasma lipid and lipoprotein concentrations during eight weeks of endurance training, Atherosclerosis 37:231–238 (1980).PubMedGoogle Scholar
  221. 78.
    P. Peltonen, J. Marniemi, E. Hietanen, I. Vuolri, C. Ehnholm, Changes in serum lipids, lipoproteins, and heparin releasable lipolytic enzymes during moderate physical training in man: a longitudinal study, Metabolism 30:518–526 (1981).PubMedGoogle Scholar
  222. 79.
    M.E. Moli, R.S. Williams, R.M. Lester, S.H. Quarfordt, A.G. Wallace, Cholesterol metabolism in non-obese women, Atherosclerosis 34:159–166 (1979).Google Scholar
  223. 80.
    R.J. Shephard, P.E. Youldon, M. Cox, C. West, Effects of a 6-month industrial fitness programme on serum lipid concentrations, Atherosclerosis 35:277–286 (1980).PubMedGoogle Scholar
  224. 81.
    E.R. Nye, K. Carlson, P. Kirstein, S. Rossner, Changes in high density lipoprotein subfractions and other lipoproteins induced by exercise, Clin Chia Acts 113:51–57 (1981).Google Scholar
  225. 82.
    T.G. Allison, R.M. Iammarino, K.F. Metz, G.S. Skrinar, L.H. Kuller, R.J. Robertson, Failure of exercise to increase high density lipoprotein cholesterol, J Card Rehab 1:257–265 (1981).Google Scholar
  226. 83.
    L.C. Lipson, R.O. Bonow, E.J. Schaefer, H.B. Brewer, F.T. Lindgren, Effect of exercise conditioning on plasma high density lipoproteins and other lipoproteins, Atherosclerosis 37:529–538 (1980).PubMedGoogle Scholar
  227. 84.
    P.D. Thompson, E. Cullinane, L.O. Henderson, P.N. Herbert, Acute effects of prolonged exercise on serum lipids, Metabolism 29:662–665 (1980).PubMedGoogle Scholar
  228. 85.
    L.A. Carlson, S.O. Froberg, Blood lipid and glucose levels during a ten-day period of low-calorie intake and exercise in man, Metabolism 16:624–634 (1967).Google Scholar
  229. 86.
    W.H. Sutherland, S.P. Woodhouse, S. Williamson, B. Smith, Decreased and continued physical activity and plasma lipoprotein lipids in previously trained men, Atherosclerosis 39:307–311 (1981).PubMedGoogle Scholar
  230. 87.
    S.C. Enger, S.B. Stromme, H.E. Refsum, High density lipoprotein cholesterol, total cholesterol and triglycerides in serum after a single exposure to prolonged heavy exercise, Scand J Clin Lab Invest 40:1–5 (1980).Google Scholar
  231. 88.
    E. A. Nikkila, J.R. Taskinen, S. Rehunen, M. Harkonen, Lipoprotein lipase activity in adipose tissue and skeletal muscle of runners: relation to serum lipoproteins, Metabolism 27:1661–1671 (1978).PubMedGoogle Scholar
  232. 89.
    P.D. Wood, W.L. Haskell, The effect of exercise on plasma high density lipoproteins, Lipids 14:417–427 (1979).PubMedGoogle Scholar
  233. 90.
    W.P. Castelli, T. Gordon, M.C. Hjortland, A. Kagan, J.T. Doyle, C.G. Hames, S.B. Hulley, W.J. Zukel, Alcohol and blood lipids, Lancet 1153–155 (1977).Google Scholar
  234. 91.
    N. Ernst, M. Fisher, W. Smith, T. Gordon, B.M. Rifkind, J.A. Little, M.A. Mishkel, O.D. Williams, The association of plasma high-density lipoprotein cholesterol with dietary intake and alcohol consumption, Circulation 62(IV):41–52 (1980).Google Scholar
  235. 92.
    K. Yano, G.G. Rhoads, A. Kagan, Coffee, alcohol and risk of coronary heart disease among Japanese men living in Hawaii, N Engl J Med 297:405–409 (1977).PubMedGoogle Scholar
  236. 93.
    P. Williams, D. Robinson, A. Bailey, High-density lipoprotein and coronary risk factors in normal men, Lancet 1:72–75 (1979).PubMedGoogle Scholar
  237. 94.
    W. Willett, C.H. Hennekens, A.J. Siegel, M.M. Adner, W.P. Castelli, Alcohol consumption and high-density lipoprotein cholesterol in marathon runners, N Engl J Med 303:1159–1161 (1980).PubMedGoogle Scholar
  238. 95.
    B.G. Johansson, A. Medhus, Increase in plasma alpha-lipoproteins in chronic alcoholics after acute abuse, Acta Med Scand 195:273–277 (1974).PubMedGoogle Scholar
  239. 96.
    P. Belfrage, B. Berg, I. Hagerstrand, P. Nilsson-Ehle, H. Tornqvist, T. Wiebe, Alterations of lipid metabolism in healthy volunteers during long-term ethanol intake, Eur J Clin Invest 7:127–131 (1977).PubMedGoogle Scholar
  240. 97.
    R.H. Schapiro, R.L. Scheig, G.D. Drummey, J.H. Mendelson, R.J. Isselbacher, Effect of prolonged ethanol ingestion on the transport and metabolism of lipids in man, N Engl J Med 272:610–615 (1965).PubMedGoogle Scholar
  241. 98.
    A. Chait, A.W. February, M. Mancini, B. Lewis, Clinical and metabolic study of alcoholic hyperlipidaemia, Lancet 11:62–64 (1972).Google Scholar
  242. 99.
    E. Baraona, C.S. Lieber, Effects of ethanol on lipid metabolism, J Lipid Res 20:289–315 (1979).PubMedGoogle Scholar
  243. 100.
    R.I. Levy, D.S. Fredrickson, N.J. Stone, D.W. Bilheimer, W.V. Brown, C.J. Glueck, A.M. Gotto, P.N. Herbert, P.O. Kwiterovich, T. Langer, J. LaRosa, S.E. Lux, A.K. Rider, R.S. Shulman, H.R. Sloan, Cholestyramine in Type II hyperlipoproteinemia, Ann Intern Med, 79:51–58 (1973).PubMedGoogle Scholar
  244. 101.
    P.T. Kuo, K. Hayase, J.B. Kostis, A.E. Moreyra, Use of combined diet and colestipol in long-term (7–71/2 years) treatment of patients with Type II hyperlipoproteinemia, Circulation 59:199–211 (1979).PubMedGoogle Scholar
  245. 102.
    M.C. Cheung, J.J. Albers, P.W. Wahl, W.R. Hazzard, High density lipoproteins during hypolipidemic therapy, Atherosclerosis 35:215–228 (1980).PubMedGoogle Scholar
  246. 103.
    J. Shepherd, C.J. Packard, A.G. Morgan, J.L. Third, J.M. Stewart, T.D. Lawrie, The effects of cholestyramine on high density lipoprotein metabolism, Atherosclerosis 33:433–444 (1979).PubMedGoogle Scholar
  247. 104.
    J.L. Witztum, G. Schonfeld, S.W. Weidman, W.E. Giese, M.A. Dilingham, Bile sequestrant therapy alters the compositions of low-density and high-density lipoproteins, Metabolism 28:221–229 (1979).PubMedGoogle Scholar
  248. 105.
    P. Schwandt, P. Weisweiler, The effect of D-thyroxine on lipoprotein lipids and apolipoproteins in primary Type IIa hyperlipoproteinemia, Atherosclerosis 35:301–306 (1980).PubMedGoogle Scholar
  249. 106.
    P.J. Nestel, D. Hunt, M.L. Wahlqvist, Clofibrate raises plasma apoprotein A-I and HDL-cholesterol concentrations, Atherosclerosis 37:625–629 (1980).PubMedGoogle Scholar
  250. 107.
    J.M. Falko, J.L. Witztum, G. Schonfeld, S.W. Weidman, J.B. Kolar, Type III hyperlipoproteinemia, Am J Med 66:303–310 (1979).PubMedGoogle Scholar
  251. 108.
    Y. Maruhama, A. Yanbe, R. Abe, A. Ohneda, S. Yamagata, Effect of clofibrate administration on plasma post-heparin lipolytic activity in man, Tohoku J Ssp Med 113:343–349 (1974).Google Scholar
  252. 109.
    S.C. Enger, J. Erikssen, V. Johnsen, A. Samuelsen, K. Herbjornsen, E.A. Laws, The effect of clofibrate on high density lipoprotein and total cholesterol in patients with coronary heart disease, Artery 4:28–35 (1978).Google Scholar
  253. 110.
    C.B. Blum, R.I. Levy, S. Eisenberg, M. Hall, R.H. Goebel, M. Berman, High density lipoprotein metabolism in man, J Clin Invest 60:795–807 (1977).PubMedGoogle Scholar
  254. 111.
    Shepherd, C.J. Packard, J.R. Patsch, A.M., O.D. Taunton, Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism, J Clin Invest 63:858–867 (1979).PubMedGoogle Scholar
  255. 112.
    C.J. Packard, J.M. Stewart, J.L. Third, H.G. Morgan, T.D. Lawrie, J. Shepherd, Effects of nicotinic acid therapy on high-density lipoprotein metabolism in Type II and Type IV hyperlipoproteinaemia, Biochim Biophys Acta 618:53–62 (1980).PubMedGoogle Scholar
  256. 113.
    J. LeLorier, S. DuBreuil-Quidoz, S. Lussier-Cacan, Y.S. Huang, J. Davignon, Diet and probucol in lowering cholesterol concentrations, Arch Intern Med 137:1429–1434 (1977).PubMedGoogle Scholar
  257. 114.
    P.J. Nestel, T. Billington, Effects of probucol on low density lipoprotein removal and high density lipoprotein synthesis, Atherosclerosis 38:203–209 (1981).PubMedGoogle Scholar
  258. 115.
    M.J. Mellies, P.S. Gartside, L. Glatfelter, P. Vink, G. Guy, G. Schonfeld, C.J. Glueck, Effects of probucol on plasma cholesterol, high and low density lipoprotein cholesterol, and apolipoproteins Al and A2 in adults with primary familial hypercholesterolemia, Metabolism 29:956–964 (1980).PubMedGoogle Scholar
  259. 116.
    L.A. Carlson, B. Kolmodin-Hedman, Hyper-alpha-lipoproteinemia in men exposed to chlorinated hydrocarbon pesticides, Acta Med Scand, 192:29–32 (1972).PubMedGoogle Scholar
  260. 117.
    L.A. Carlson, B. Kolmodin-Hedman, Decrease in alpha-lipoprotein cholesterol in men after cessation of exposure to chlorinated hydrocarbon pesticides, Acta Med Scared 201:375–376 (1977).Google Scholar
  261. 118.
    E.A. Nikkila, M. Kaste, C. Ehnholm, J. Viikari, Increase of serum high-density lipoprotein in phenytoin users, Br Med J 2:99 (1978).PubMedGoogle Scholar
  262. 119.
    G.D. Bell, J.P. Bradshaw, A. Burgess, W. Ellis, J. Hatton, A. Middleton, B. Middleton, T. Orchard, D.A. White, Elevation of serum high density lipoprotein cholesterol by rowachol, a proprietary mixture of six pure monoterpenes, Athersclerosis 36:47–54 (1980).Google Scholar
  263. 120.
    M.H. Crique, R.B. Wallace, G. Heiss, M. Mishkel, G. Schonfeld, G.T. Jones, Cigarette smoking and plasma high-density lipoprotein cholesterol, Circulation 62(IV):70–76 (1980).Google Scholar
  264. 121.
    R.J. Garrison, W.B. Kannel, M. Feinleib, W.P. Castelli, P.M. McNamara, S.J. Padgett, Cigarette smoking and HDL cholesterol, Atherosclerosis 30:17–25 (1978).PubMedGoogle Scholar
  265. 122.
    J. Erikssen, S.C. Enger, The effect of smoking on selected coronary heart disease risk factors in middle-aged men, Acta Med Scand 203:27–30 (1978).PubMedGoogle Scholar
  266. 123.
    K. Berg, A.L. Borresen, G. Dahlen, Effect of smoking on serum levels of HDL apoproteins, Atherosclerosis 34:339–343 (1979).PubMedGoogle Scholar
  267. 124.
    P. Leren, A. Helgeland, I. Holme, P.O. Foss, I. Hjermann, P.G. Lund-Larsen, Effect of propranolol and prazosin on blood lipids, Lancet 11:4–6 (1980).Google Scholar
  268. 125.
    T. Rosenthal, E. Holtzman, P. Segal, The effect of chlorthalidone on serum lipids and lipoproteins, Athersclerosis 36:111–115 (1980).Google Scholar
  269. 126.
    D.D. Bradley, J. Wingerd, D.B. Petitti, R.M. Krauss, S. Ramcharan, Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins, N Bugj. J Med 299:17–20 (1978).Google Scholar
  270. 127.
    J.R. Masarei, B.K. Armstrong, M.W. Skinner, T. Ratajczak, R. Hahnel, D. Crooke, H.T. Clarke, HDL-cholesterol and sex-hormone status, Lancet 1:208 (1980).PubMedGoogle Scholar
  271. 128.
    A. Solyom, Effects of androgens on serum lipids and lipoproteins, Lipids 7:100–105 (1971).Google Scholar
  272. 129.
    R.H. Furman, P. Alaupovic, R.P. Howard, Effects of androgens and estrogens on serum lipids and the composition and concentration of serum lipoproteins in normolipemic and hyperlipidemic states, Prog Biochem Pharaacol 2:215–249 (1967).Google Scholar
  273. 130.
    W. Insull, R.T. Kirkland, J.L. Probstfield, B.S. Keenan, G.W. Clayton, Control of HDL-cholesterol plasma levels by testosterone in pubertal males, Circulation 64(IV):113 (1981).Google Scholar
  274. 131.
    A. Nordoy, A. Aakvaag, D. Thelle, Sex hormones and high density lipoproteins in healthy males, Atherosclerosis 34:431–436 (1979).PubMedGoogle Scholar
  275. 132.
    J.A. Morrison, J. Gutal, T.J. Orchard, P.R. Khoury, W. Dai, R.E. LaPorte, C.J. Glueck, Plasma testosterone and high density lipoprotein cholesterol in adolescence: a marked absence of association, Circulation 64(IV):113 (1981).Google Scholar
  276. 133.
    E. Manzato, R. Fellin, G. Baggio, S. Wasch, W. Neubeck, D. Seidel, Formation of lipoprotein-X, J Clin Invest 57:1248–1260 (1976).PubMedGoogle Scholar
  277. 134.
    R.L. Patten, D. Hewitt, G.T. Waldman, G. Jones, J.A. Little, Associations of plasma high-density lipoprotein cholesterol with clinical chemistry data, Circulation 62(IV):31–41 (1980).Google Scholar
  278. 135.
    D.B. Petitti, G.D. Friedman, A.L. Klatsky, Association of a history of gallbladder disease with a reduced concentration of high-density-lipoprotein cholesterol, N Engl J Med 304:1396–1398 (1981).PubMedGoogle Scholar
  279. 136.
    G.D. Calvert, T. Mannik, J.J. Graham, P.H. Wise, R.A. Yeates, Effects of therapy on plasma-high-density-lipoproteincholesterol concentration in diabetes mellitus, Lancet 2:66–68 (1978).PubMedGoogle Scholar
  280. 137.
    R.S. Elkeles, J. Wu, J. Hambley, Haemoglobin Al, blood glucose, and high-density lipoprotein cholesterol in insulin-requiring diabetics, Lancet 11:547–548 (1978).Google Scholar
  281. 138.
    C.A. Hornick, B.D. Fellmeth, High density lipoprotein cholesterol, insulin, and obesity in Samoans, Atherosclerosis 39:321–328 (1981).PubMedGoogle Scholar
  282. 139.
    F.L. Dunn, A. Pietri, P. Raskin, Plasma lipid and lipoprotein levels with continuous subcutaneous insulin infusion in Type I diabetes mellitus, Ann Intern Med 95:426–431 (1981).PubMedGoogle Scholar
  283. 140.
    G.M. Tisi, A. Conrique, E. Barrett-Connor, S.M. Grundy, Increased high density lipoprotein cholesterol in obstructive pulmonary disease (predominant emphysematous type), Metabolism 30:340–346 (1981).PubMedGoogle Scholar
  284. 1.
    Morrisett, J.D., Jackson, R.L., Gotto, A.M., Jr., Lipoproteins: structure and function, Ann. Rev. Biochem., 44: 183 (1975), J. Biol. Chem., 249: 5314 (1974).PubMedGoogle Scholar
  285. 2.
    Jackson, R.L., Morrisett, J.D., Gotto A.M., Jr., Segrest, J.P., The mechanism of lipid-binding by plasma lipoproteins, Mol. Cell Biochem., 6: 43 (1975).PubMedGoogle Scholar
  286. 3.
    Jackson R.L., Morrisett, J.D., Gotto, A.M., Jr., Lipoproteins and lipid transport: Structural and functional concepts, in: Hyperlipidemia, Diagnosis and Therapy, Levy, R.I., Iifkind, B.M., eds., p.1, Grune and Stratton, New York (1977).Google Scholar
  287. 4.
    Brewer, H.B., Jr., Lux, S.E., Ronan, R., John, K.M., Amino acid sequence of human apo Lp-Gln-II (apo A-II), an apolipoprotein isolated from the high density lipoprotein complex, Proc. Natl. Acad. Sci., USA,69: 1304 (1972).PubMedGoogle Scholar
  288. 5.
    Btaker, H.N., Delahunty, T., Gotto, A.M., Jr., Jackson, R.L., The primary structure of high density apolipoprotein-glutamine-I, Proc. Nati. Acad. Sci., USA„ 71: 3631 (1974).Google Scholar
  289. 6.
    Brewer, H.B., Jr., Fairwell, T., Larne, A., Ronan, R., Houser, A., Bronzert, T.J., The amino acid sequence of human apo A-I, an apolipoprotein isolated from high density lipoproteins, Biochem. Biophys. Res. Comm., 80: 623 (1978).PubMedGoogle Scholar
  290. 7.
    Nicols, A., Miller, N.E., Lewis, B., High-density lipoprotein metabolism, Adv. Lipid Res., 17: 53 (1980).Google Scholar
  291. 8.
    Fielding, C.J., Shore, V.G., Fielding, P.E., A protein cofactor of lecithin: cholesterol acyltransferase, Biochem. Biophys. Res. Comm., 46: 1493 (1972).PubMedGoogle Scholar
  292. 9.
    Albers, J.J., Lecithin: cholesterol acyltransferase, Artery, 5: 61 (1979).PubMedGoogle Scholar
  293. 10.
    Aoutar A.K., Garner, C.W., Baker, H.N., Sparrow, J.T., Jackson, R.L., Gotto, A.M., Smith, L.C., Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase, Biochemistry, 14: 3057 (1975).Google Scholar
  294. 11.
    Glomset, J.A., The plasma lecithin: cholesterol acyltransferase reaction, J. Lipid Res., 9: 155 (1968).PubMedGoogle Scholar
  295. 12.
    Schmitz, G., Assmann, G., Melnik, B., The role of lecithin: cholesterol acyltransferase in high density lipoprotein-3/high density lipoprotein-2 interconversion in man, Clin. Chim. Acta, in press (1981).Google Scholar
  296. 13.
    Mhmitz, G., Assmann, G., Isolation of human serum HDL-1 by zonal ultracentrifugation, J. Lipid. Res., submitted (1981).Google Scholar
  297. 14.
    Nestruck, A.C., Suzue, G., Marcel, Y.L., Studies on the polymorphism of human apolipoprotein A-I, Biochim. Biophys. Acta, 617: 110 (1980).PubMedGoogle Scholar
  298. 15.
    Franceschini, G., Sirtori, C.R., Capurso, A., Weisgraber, K.H., Mahley, R.W., A-I-Milano Apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family, J. Clin. Invest., 66: 892 (1980).PubMedGoogle Scholar
  299. 16.
    Weisgraber, K.H., Bersot, T.P., Mahley, R.W., Franceschini, G., Sirtori, C.R., A-I-Milano Apoprotein. Isolation and characterization of a cystein-containing variant of the A-I apoprotein from human high density lipoprotein, J. Clin. Invest., 66: 901 (1980).PubMedGoogle Scholar
  300. 17.
    Mtermann, G., Steinmetz, A., Haas, J., Feusner, G., Fran- ceschini, G., Apolipoproteinopathies: rapid method for screening and characterization of genetic apolipoprotein A variants, J. Biol. Chem., in press (1981).Google Scholar
  301. 18.
    Menzel, H.-J., Dittmar, K., Assmann, G., One step screening method for the polymorphism of apolipoproteins A-I, A-II and A-IU, J. Lipid. Res., submitted (1981).Google Scholar
  302. 19.
    Assmann, G., Smootz, E., Adler, K., Capurso, A., Oette, K., The lipoprotein abnormality in Tangier disease, quantification of A-apoproteins, J. Clin. Invest., 59: 565 (1977).PubMedGoogle Scholar
  303. 20.
    Assmann, G., Simantke, O., Schaefer, H.-E., Smooth, E., Characterization of high density lipoproteins in patients heterozygous for Tangier disease, J. Clin. Invest., 60: 1025 (1977).PubMedGoogle Scholar
  304. 21.
    Mao, S.J.T., Sparrow, J.T., Gilliam, E.B., Gotto, A.M., Jr., Jackson, R.L., Mechanism of lipid-protein interaction in the plasma lipoproteins: the lipid-binding properties of synthetic fragments of apolipoprotein A-II, Biochemistry, 16: 4150 (1977).PubMedGoogle Scholar
  305. 22.
    Segrest, J.P., Jackson, R.L., Morrisett, J.D., Gotto, A.M., Jr., A molecular theory of lipid protein interactions in the plasma lipoproteins, FEBS Let., 38: 247 (1974).Google Scholar
  306. 23.
    Mao, S.J.T., Jackson, R.L., Gotto, A.M., Sparrow, J.T., Mechanism of lipid-protein interaction in the plasma lipoproteins: Identification of a lipid binding site in apolipoprotein A-II, Biochemistry, 20: 1676 (1981).PubMedGoogle Scholar
  307. 24.
    Kostner, G.M., Studies of the composition and structure of human serum lipoproteins: Isolation and partial characterization of apolipoprotein A-III, Biochim. Biophys. Acta, 336: 383 (1974).Google Scholar
  308. 25.
    McConathy, W.J., Alaupovic, P., Isolation and partial charaterization of apolipoprotein D: A new protein moiety of the human plasma lipoprotein system, FEBS Let., 37: 178 (1973).Google Scholar
  309. 26.
    Kostner, G., Studies on the cofactor requirement for lecithin: Cholesterol acyltransferase, Scand. J. Clin. Lab. Invest., 33 suppl. 137: 19 (1974).Google Scholar
  310. 27.
    Chajek, T., Fielding, C.J., Isolation and characterization of a human serum cholesteryl ester transfer protein, Proc. Natl. Acad. Sci., USA, 75: 3445 (1978).PubMedGoogle Scholar
  311. 28.
    Fielding, P.E., Fielding, C.J., A cholesteryl ester transfer complex in human plasma, Proc. Natl. Acad. Sci., USA, 77: 3327 (1980).PubMedGoogle Scholar
  312. 29.
    Fielding, C.J., Fielding, P.E., Regulation of human plasma lecithin cholesterol acyltransferase activity by lipoprotein acceptor cholesteryl ester content, J. Biol. Chem., 256: 2102 (1981).PubMedGoogle Scholar
  313. 30.
    Green, P.H.R., Glickman, R.M., Riley, J.W., Quinet, E., Human apolipoprotein A-IV. Intestinal origin and distribution in plasma, J. Clin. Invest., 65: 911 (1980).PubMedGoogle Scholar
  314. 31.
    Weisgraber, K.H., Bersot, T.P., Mahley, R.W., Isolation and characterization of an apoprotein from the d C 1.006 lipoproteins of human and canine lymph homologous with the rat A-IV apoprotein, Biochem. Biophys. Res. Commun., 85: 287 (1978).PubMedGoogle Scholar
  315. 32.
    Utermann, G., Beisiegel, U., Apolipoprotein A-IV: A protein occuring in human mesenteric lymph chylomicrons and free in plasma, Europ. J. Biochem., 99: 33 (1979).Google Scholar
  316. 33.
    Kane, J.P., Hardman, D.A., Paulus, H.E., Heterogeneity of apolipoprotein B: Isolation of a new species from human chylomicrons, Proc. Natl. Acad. Sci., USA, 77: 2465 (1980).PubMedGoogle Scholar
  317. 34.
    Havel, R.J., International Congress for Clinical Chemistry, Wien (1981).Google Scholar
  318. 35.
    Brown, M.S., Kovanen, P.T., Goldstein, J.L., Regulation of plasma cholesterol by lipoprotein receptors, Science, 212: 628 (1981).PubMedGoogle Scholar
  319. 36.
    Shepherd, J., Bicker, S, Lorimer, A.R., Packard, C.J., Receptor-mediated low density lipoprotein catabolism in man, J. Lipid. Res., 20: 999 (1979).PubMedGoogle Scholar
  320. 37.
    Shepherd, J., Packard, C.J., Bicker, S., Lawrie, T.D.V., Morgan, H.G., Cholesterylamine promotes receptor-mediated low-density-lipoprotein catabolism, N. Engl. J. Med., 302: 1219 (1980).PubMedGoogle Scholar
  321. 38.
    Malloy, M.J., Kane, J.P., Hardann, D.A., Hamilton, R.L., Dalal, K.B., Normotriglyceridemic Abetalipoproteinemia. Absence of the B-100 apolipoprotein, J. Clin. Invest., 67: 1441 (1981).PubMedGoogle Scholar
  322. 39.
    Schonfeld, G., Lees, R.S., George, P.K., Pfleger, B., Assay of total plasma apolipoprotein B concentration in human subjects, J. Clin. Invest., 53: 1458 (1974).PubMedGoogle Scholar
  323. 40.
    Albers, J.J., Cabana, V.G., Hazzard, W.R., Immunoassay of human plasma apolipoprotein B, Metabolism, 24: 1339 (1975).PubMedGoogle Scholar
  324. 41.
    Utermann, G., Lipp, K., Wiegandt, H., Studies on the Lp(a)-lipoprotein of human serum, IV. The disaggregation of the Lp(a)-lipoprotein, Humangenetik, 14: 142 (1972).PubMedGoogle Scholar
  325. 42.
    Albers, J.J., Adolphons, J.L., Hazzard, W.R., Radioimmunoassay of human plasma Lp(a) lipoprotein, J. Lipid. Res., 18: 331 (1977).PubMedGoogle Scholar
  326. 43.
    Kostner, G.M., Avogardo, P., Cazzolato, G., Marth, E., Bittolo-Bon, G., Quinci, G.B., Lipoprotein Lp(a) and the risk for myocardial infarction, Atherosclerosis, 38: 51 (1981).PubMedGoogle Scholar
  327. 44.
    Shulman, R.S., Herbert, P.N., Wehrly, K., Fredrickson, D.S., The complete amino acid sequence of C-I (Apo Lp-Ser), an apolipoprotein from human very low density lipoproteins, J. Biol. Chem.,250: 182 (1975)PubMedGoogle Scholar
  328. 45.
    acksson, R.L., Sparrow, J.T., Baker, H.N., Morrisett, J., Taunton, O.D., Gotto, A.M., Jr.,The primary structure of apolipoprotein-serine, J. Biol. Chem., 249: 5308, (1974).Google Scholar
  329. 46.
    Jackson, R.L., Baker, H.N., Gilliam, E.B., Gotto, A.M., Jr., Primary structure of very low density apolipoprotein C-II of human plasma, Proc. Natl. Acad. Sci., USA, 74: 1942 (1977).PubMedGoogle Scholar
  330. 47.
    Brewer, H.B., Shulman, R., Herbert, P., Ronan, R., Wehrly, K., The complete amino acid sequence of alanine apolipoprotein (apo C-III), an apolipoprotein from human plasma very low density lipoproteins, J. Biol. Chem., 249: 4975 (1974).PubMedGoogle Scholar
  331. 48.
    Jackson, R.L., Morrisett, J.D., Sparrow, J.R., Segrest, J.P., Pownall, H.J., Smith, L.C., Hoff, H.F., Gotto, A.M., Jr., The interaction of apolipoprotein-serine with phosphatidylcholine, J. Biol. Chem., 249: 5314 (1974).PubMedGoogle Scholar
  332. 49.
    Kashyap, M.L., Srivastava, L.S., Chen, C.Y., Perisutti, G., Campbell, M., Lutmer, R.J.F., Glueck, C.J., Radioimmunoassay of human apolipoprotein C-II. A study in normal and hypertriglyceridemic subjects, J. Clin. Invest., 60: 171 (1977).PubMedGoogle Scholar
  333. 50.
    Havel, R.J., Shore, V.G., Shore, B., Biou, D.M., Role of the specific glycopeptides of human serum lipoproteins in the activation of lipoprotein lipase, Circ. Res., 27: 595 (1970).PubMedGoogle Scholar
  334. 51.
    LaRosa, J.C., Levy, R.I., Herbert, P.N., Lux, S.E., Fredrickson, D.S., A specific apoprotein activator for lipoprotein lipase, Biochem. Biophys. Res. Commun., 41: 57 (1970).PubMedGoogle Scholar
  335. 52.
    Smith, L.C., Voyta, J.C., Catapano, A.L., Kinnunen, P.K.J., Gotto, A.M., Jr., Sparrow, J.T., Activation of lipoprotein lipase by synthetic fragments of apo C-II, in: Atherosclerosis V, Gotto, A.M., Jr., Smith, L.C., Allen, B., eds., p. 397, Springer-Verlag, New York (1980).Google Scholar
  336. 53.
    Musliner, T.A., Herbert, P.N., Church, E.C., Activation of lipoprotein lipase by native and acylated peptides of apolipoprotein C-II, Biochim. Biophys. Acta, 573: 501 (1979).PubMedGoogle Scholar
  337. 54.
    Kinnunen, P.K.J., Jackson, R.L., Smith, L.C., Gotto, A.M., Sparrow, J.T., Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein C-II, Proc. Natl. Acad. Sci., USA, 74: 4848 (1977).PubMedGoogle Scholar
  338. 55.
    Breckenridge, W.C., Little, J.A., Steiner, G., Chow, A., Poapst, M., Hypertriglyceridemia associated with deficiency of apolipoprotein C-II, N. Engl. J. Med., 298: 1265 (1978).PubMedGoogle Scholar
  339. 56.
    Havel, R., Kotite, L., Kane, J., Isoelectric heterogeneity of the cofactor protein for lipoprotein lipase and human blood plasma, Biochem. Med., 21: 121 (1979).PubMedGoogle Scholar
  340. 57.
    Catapano, A.L., The distribution of apo C-II and apo C-III in very low density lipoproteins of normal and type IV subjects, Atherosclerosis, 35: 419 (1980).PubMedGoogle Scholar
  341. 58.
    Curry, M.D., McConathy, W.J., Fesmire, J.D., Alaupovic, P., Quantitative determination of human apolipoprotein C-III by electro-immunoassay, Biochim. Biochphys. Acta, 617: 503 (1980).Google Scholar
  342. 59.
    Brown, W.V., Baginsky, M.L., Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein, Biochem. Biophys. Res. Commun., 46: 375 (1972).PubMedGoogle Scholar
  343. 60.
    Kraus, R.M., Herbert, P.N., Levy, R.I., Fredrickson, D.S., Further observations on the activation and inhibition of lipoprotein lipase by apolipoproteins, Cire. Res., 33: 403 (1973).Google Scholar
  344. 61.
    Zannis, V.I., Breslow, J.L., Characterization of a unique human apolipoprotein E variant associated with type III hyperlipoproteinemia, J. Biol. Chem., 255: 1759 (1980).PubMedGoogle Scholar
  345. 62.
    Shelburne, F.A., Quarfordt, S.H., A new apoprotein of human plasma very low density lipoproteins, J. Biol. Chem., 249: 1428 (1974).PubMedGoogle Scholar
  346. 63.
    Weisgraber, K.H., Mahley, R.W., Apoprotein (E-A-II) complex of human plasma lipoproteins, J. Biol. Chem., 253: 6281 (1978).PubMedGoogle Scholar
  347. 64.
    Innerarity, T.L., Mahley, R.W., Weisgraber, K.H., Bersot, T.P., Apoprotein (E-A-II) complex of human plasma lipoprotein. II. Receptor binding activity of a high density lipoprotein subfraction modulated by apo (E-A-II) complex, J. Biol. Chem., 253: 6289 (1978).PubMedGoogle Scholar
  348. 65.
    A.-L., Windmüller, H.G., Relative contributions by liver and intestine to individual plasma apolipoproteins in the rat, J. Biol. Chem., 254: 7316 (1979).Google Scholar
  349. 66.
    Uterman, G.N., Jaeschke, M., Menzel, J., Familial hyperlipoproteinemia Type III: Deficiency of a specific apolipoprotein (apo E-III) in the very low density lipoproteins, FEBS Let., 56: 352 (1975).Google Scholar
  350. 67.
    Havel R.J., Kotite, L., Vigne, J.-L., Kane, J.P., Tun, P., Phillips, N., Chen, G.C., Radioimmunoassay of human argininerich apolipoprotein, apoprotein E. Concentration in blood and lipoproteins as affected by apoprotein E-3 deficiency, J. Clin. Invest., 66: 1351 (1980).PubMedGoogle Scholar
  351. 68.
    Kushwaha, R.S., Hazzard, W.R., Wahl, P.W., Hoover, J.J., Type III hyperlipoproteinemia: Diagnosis in whole plasma by apolipoprotein-E immunoassay, Ann. Intern. Med., 87: 509 (1977).PubMedGoogle Scholar
  352. 69.
    Zannis, V.I., Breslow, J.L., Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification, Biochemistry, 20: 1033 (1981).PubMedGoogle Scholar
  353. 70.
    Zannis, V.J., Just, P.W., Breslow, J.L., Human apolipoprotein E isoprotein subclasses are genetically determined, Amer. J. Hum. Genet., 33: 11 (1981).PubMedGoogle Scholar
  354. Weisgraber, K.H., Rall, S.C., Jr., Mahley, R.W., Human E apoprotein heterogeneity: Cystein-arginine interchanges in the amino acid sequence of the apo-E isoforms, J. Biol. Chem., in press (1981).Google Scholar
  355. 72.
    Chao, Y.-S., Windier, E.E., Chen, G.C., Havel, R.J., Hepatic catabolism of rat and human lipoproteins in rats treated with 17 alpha-ethinyl estradiol, J. Biol. Chem., 254: 11360 (1979).PubMedGoogle Scholar
  356. 73.
    Pitas, R.E., Innerarity, T.L., Mahley, R.W., Cell surface receptor binding of phospholipid protein complexes containing different ratios of receptor-active and -inactive E apoprotein, J. Biol. Chem., 255: 5454 (1980).PubMedGoogle Scholar
  357. 74.
    Innerarity, T.L., Pitas, R.E., Mahley, R.W., Receptor binding of cholesterol-induced high-density lipoproteins containing predominantly apoprotein E to cultured fibroblasts with mutations at the low-density lipoprotein receptor locus, Biochemistry, 19: 4359 (1974).Google Scholar
  358. 75.
    Havel, R.J., Chao, Y.-S., Windier, E.E., Kolite, L., Guo, L.S.S., Isoprotein specificity in the hepatic uptake of apolipoprotein E and the pathogenesis of familial dysbetalipoproteinemia, Proc. Natl. Acad. Sci., USA, 77: 4349 (1980).PubMedGoogle Scholar
  359. 76.
    Assmann, G., Tangier-Krankheit, in: Stoffwelchselkrankheiten, Schettler, G., Greten, H., Srehlierf, G., Seidel, D., eds., Springer-Verlag, Berlin Heidelberg New York (Handbuch der Inneren Medizin, 5, Aufl. Bd. VII Teil 4, S. 461) (1976).Google Scholar
  360. 77.
    Assmann, G., Die Tangier-Krankheit - Klinik and Pathophysiologie, Klin. Wschr., 57: 53 (1979).PubMedGoogle Scholar
  361. 78.
    Herbert, P.N., Gotto, A.M., Fredrickson, D.S., Familial lipoprotein deficiency (abetalipoproteinemia, hypobetalipoproteinemia and Tangier disease), in: The metabolic basis of inherited disease, Stanbury, J.B., Wyngaarden, J.B., Fredrickson, D.S., eds., p. 544 (Ch. 28), McGraw-Hill, New York (1978).Google Scholar
  362. 79.
    Assmann G., Tangier disease and the possible role of high density lipoproteins in atherosclerosis, Atherosclerosis Rev., 6: 1 (1979).Google Scholar
  363. 80.
    Herbert, P.N., Assman, G., Gotto, A.M., Fredrickson, D.S., Familial lipoprotein deficiency (abetalipoproteinemia, hypobetalipoproteinemia and Tangier disease), in: The metabolic basis of inherited disease, Stanbury, M.S., Wyngaarden, J.B., Fredrickson, D.S., Goldstein, J.L., Brown, M.S., eds., Ch. 29, McGraw-Hill, in press (1982).Google Scholar
  364. 81.
    Ferrans, V.I., Fredrickson, D.S., The pathology of Tangier disease. A light and electron microscopic study, Am. J. Pathol., 78: 101 (1975).PubMedGoogle Scholar
  365. 82.
    Katz, S.S., Small, D.M., Brook, I.G., Lees, R.W., The storage lipids in Tangier disease. A physical chemical study, J. Clin. Invest., 59: 1045 (1977).PubMedGoogle Scholar
  366. 83.
    Herbert, P.N., Heinen, R.J., Bausserman, L.L., Henderson, L.O., Musliner, T.A., Abetalipoproteinemia and hypobetalipoproteinemia: question still exceed insights, in: Atherosclerosis V. Proceedings of the fifth international symposium on atherosclerosis, Gotto, A.M., Jr., Smith, L.C., Allem, B., eds., p. 684–688, Springer Verlag, New York (1980).Google Scholar
  367. 84.
    Herbert, P.N., Fredrickson, D.S., The hypobetalipoproteinemias, in: HandbUch der Inneren Medizin, VII/4, Fettstoffwechsel, Schettler, G., Greten, H., Schlierf, G., Seidel, D., eds., p. 485, Springer Verlag, Heidelberg (1976).Google Scholar
  368. 85.
    Cox, D.W., Breckenridge, W.C., Little, J.A., Inheritance of apolipoprotein C-II deficiency with hypertriglyceridemia and pancreatitis, N. Engl. J. Med., 299: 1421 (1978).PubMedGoogle Scholar
  369. 86.
    Yamamura, T., Sudo, H., Ishikawa, K., Yamamoto, A., Familial type I hyperlipoproteinemia caused by apolipoprotein C-II deficiency, Atherosclerosis, 34: 53 (1979).PubMedGoogle Scholar
  370. 87.
    Capurso, A., Pace, L., Bonomo, L., Catapano, A., Schiliro, G., LaRosa, M., Assmann, G., New case of apoprotein C-II deficiency, Lancet 1, 268 (1980).PubMedGoogle Scholar
  371. 88.
    Crepaldi, G., Fellin, R., Baggio, G., Augustin, J., Greten, H., Lipoprotein and apoprotein, adipose tissue and hepatic lipoprotein lipase levels in patients with familial hyperchylomicronemia and their immediate fan;ily members, in: Atherosclerosis V, Gotto, A.M., Jr., Smith, L.C., Allen, B., eds., p. 250, Springer-Verlag, New York (1980).Google Scholar
  372. 89.
    Miller, N.E., Rao, S.N., Alaupovic, P., Noble, N., Slack, J., Brunzell, J.D., Lewis, B., Familial apolipoprotein C-II deficiency, plasma lipoproteins and apolipoprotein in heterozygous and homozygous subjects and the effects of plasma infusion, Eur. J. Clin. Invest., 11: 69 (1981).PubMedGoogle Scholar
  373. 90.
    Utermann, G., Hees, M., Steinmetz, A., Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinemia in men, Nature, 269: 604 (1977).PubMedGoogle Scholar
  374. 91.
    Utermann, G., Pruin, N., Steinmetz, A., Effect of a single polymorphic gene locus on plasma lipid levels in man, Clin. Genet., 15: 63 (1979).PubMedGoogle Scholar
  375. 92.
    Havel, R.J., Goldstein, J.L., Brown, M.S., Lipoproteins and lipid transport, in: Metabolic control and disease, 8th ed., Bondy, P.K., Rosenberg, L.E., eds., p. 393 (Ch. 7), Saunders, W.B. Co, Philadelphia (1980).Google Scholar
  376. 93.
    Gregg, R.E., Zech, L.A., Schaefer, E.J., Brewer, H.B., Jr., Type III hyperlipoproteinemia: Defective metabolism of an abnormal apolipoprotein E, Science, 211: 584 (1981).PubMedGoogle Scholar
  377. 94.
    Fredrickson, D.S., Levy, R.I., Lees, R.S., Fat transport in lipoproteins - an integrated approach to mechanisms and disorders, N. Engl. J. Med., 276: 32, 94: 148, 215: 273 (1967).Google Scholar
  378. 95.
    Havel, R.J., Kane, J.P., Primary dysbetalipoproteinemia: Predominance of a specific apolipoprotein species in triglyceride-rich lipoproteins, Proc. Natl. Acad. Sci., USA, 70: 2015 (1973).PubMedGoogle Scholar
  379. 96.
    Brown, M.S., Goldstein, J.L., Fredrickson, D.S., Familial type 3 hyperlipoproteinemia, in: The metabolic basis of inherited disease, Stanbury, J.B., Wyngaarden, J.B., Fredrickson, D.S., Goldstein, J.L., Brown, M.S., eds., Ch. 32, McGraw-Hill, New York, in press (1982).Google Scholar
  380. 97.
    Utermann, G., Langenbeck, U., Beisiegel, U., Weber, W., Genetics of the Apo-E-system in man, Am. J. Hum. Genet., 32: 339 (1980).PubMedGoogle Scholar
  381. 98.
    Utermann, G., Vogelberg, K.H., Steinmetz, A., Schoenborn, W., Pruin, N., Jaeschke, M., Hees, M., Canzler, H., Polimorphism of apolipoprotein E, Clin. Genet., 15: 37 (1979).PubMedGoogle Scholar
  382. 99.
    Morganroth, J., Levy, R.I., Fredrickson, D.S., The biochemical, clinical and genetic features of type III hyperlipoproteinemia, Ann. Intern. Med., 82: 158 (1975).PubMedGoogle Scholar
  383. 100.
    Levy, R.I., Assmann, G., Type III - Hyperlipoproteinemia, in: Stoffwechselkrankheiten, Schettler, G., Greten, H., Schlief, G., Seidel, D., eds., Springer-Verlag, Berlin Heidelberg New York (Handbuch der Inneren Medizin, 5, Aufl. Bd. VII Teil 4, S. 301) (1976).Google Scholar
  384. 101.
    Masket, B.H., Levy, R.I., Fredrickson, D.S., The use of polyacrylamide electrophoresis in differentiating type III hyperlipoproteinemia, J. Lab. Clin. Med:, 82: 794 (1973).Google Scholar
  385. 102.
    Schneider, J., Maurer, M., Kaffarnik, H., Häufigkeit der Hyperlipoproteinämie Typ III bei elektrophoretisch nachweisbarer breiter -Bande, Klin. Wschr., 52: 941 (1974).PubMedGoogle Scholar
  386. 103.
    Fredrickson, D.S., Morganroth, J., Levy, R.I., Type III hyperlipoproteinemia: An analysis of two contemporary definitions, Ann. Intern. Med., 82: 150 (1975).PubMedGoogle Scholar
  387. 104.
    Mishkel, M., Nazir, D.J., Crother, S., A longitudinal assessment of lipid ratios in the diagnosis of type III hyperlipoproteinemia, Clin. Chim. Acta, 58: 121 (1975).PubMedGoogle Scholar
  388. 105.
    Hazzard, W.R., Porte, D., Bierman, E.L., Abnormal lipid composition of very low density lipoproteins in diagnosis of broad beta disease (type III hyperlipoproteinemia), Metabolism, 21: 1009 (1972).PubMedGoogle Scholar
  389. 106.
    Finann, G., Albrecht, G., Steinmetz, A., Polymorphism of Apolipoprotein E. I. Methodological aspects and diagnosis of hyperlipoproteinemia type III without ultracentrifugation, Clin. Genet., 14: 351 (1978).Google Scholar
  390. 107.
    Tiarrnick, G.R., Mayfield, C., Albers, J.J., Hazzard, R.W., Gel isoelectric focussing method for specific diagnosis of familial hyperlipoproteinemia type III, Clin. Chem., 25: 279 (1979).Google Scholar
  391. 108.
    Weidman, S.W., Suarez, B., Falko, J.M., Witzum, J.L., Kolar, J., Raben, M., Schonfeld, G., Type III hyperlipoproteinemia: Development of a VLDL Apo E gel isoelectric focusing technique and application in family studies, J. Lab. Clin. Med., 93: 549 (1979).PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • Peter N. Herbert
    • 1
    • 2
  • Linda L. Bausserman
    • 1
  • Paul D. Thompson
    • 2
  • Richard S. Shulman
    • 2
  • G. Assmann
    • 3
  • H.-J. Menzel
    • 3
  1. 1.Brown University Program-in-Medicine, Division of Nutrition and MetabolismThe Miriam HospitalProvidenceUSA
  2. 2.Brown University Program in Medicine, Divisions of Cardiology, and Nutrition and MetabolismThe Miriam HospitalProvidenceUSA
  3. 3.Zentrallaboratorium der Medizinischen EinrichtungenWestfälischen Wilhelms-UniversitätMünsterWest Germany

Personalised recommendations